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ABSTRACT
RNA interference (RNAi) mediates potent antiviral response across kingdoms. In
Caenorhabditis elegans nematodes, antiviral RNAi requires a virus sensor that is
conserved in mammals and is amplified by secondary small interfering RNAs that are
produced in a Dicer-independent manner.
To better understand worm antiviral RNAi, I carried out a biased genetic screen, aiming
to identify novel antiviral RNAi genes. To speed up the gene discovery process, the
reporter worms used for this genetic screen were engineered to contain extra copies of 4
known antiviral RNAi genes. Therefore, genetic alleles derived from these 4 genes will be
automatically rejected during screening process. Since a viral replicon transgene was used
as reporter for loss of antiviral RNAi my genetic screen was expected to identify genes
required for antiviral RNAi but not artificial double-stranded RNA (dsRNA) triggered
RNAi.
My genetic screen identified altogether 25 candidate alleles that appear to have derived
from 13 candidate genes. Through genetic complementation tests and coding region
sequencing I confirmed that 2 of the candidate genes are known antiviral RNAi genes rde3 and rrf-1. Of the rest 11 candidate genes, 9 were found not to be required for classical
RNAi. Interestingly, Orsay virus infection assay further suggested that 7 of these 9
candidate genes are dispensable for antiviral RNAi against Orsay virus. Since Orsay virus
specifically infects intestine cells which have much weaker antiviral activity I believe that
these 7 genes mainly function in non-intestine cells.
Through whole genome sequencing I identified 2 of the candidate genes as rsd-6 and
mut-16, 2 known genes required for artificial dsRNA triggered RNAi. Currently, rsd-6 and
mut-16 are not known to play a role in antiviral RNAi. Thus, my genetic screen, for the
first time, identified both rsd-6 and mut-16 as key components for antiviral RNAi.
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CHAPTER 1: GENERAL INTRODUCTION
1.1 Caenorhabditis elegans
C. elegans is a type of round worms in nematode phylum. The C. elegans adults are
typically 1 mm in-length. They feed on bacteria, usually the E. coli species [10]. C.
elegans can be easily maintained in the lab by growing on agar seeded with bacteria food
[11].

The basic anatomy of C. elegans includes mouth, pharynx, intestine, and gonad. C.
elegans has two sexes: hermaphrodites and males [12]. Hermaphrodites have two ovaries,
oviducts, spermatheca, and a single uterus [12], while males have a single gonad, a vas
deferens, and a fan tail for mating (Fig 1).

Fig 1. Anatomical features of an adult C. elegans hermaphrodite (top) and male (bottom) [1].
They all have mouth, pharynx, gonad, intestine. The major differences between hermaphrodites
and males is that males only have one single-lobed gonad and a specialized fan tail for mating.
(From Sulston and Horvitz [6] )

C. elegans has five pairs of autosomes and one pair of sex chromosomes [12].
Hermaphrodite C. elegans has a pair of sex chromosomes (XX), but the males have only
1

one sex chromosome (X0) [12]. Hermaphrodites can be maintained by self-fertilizing.
Males are able to be produced by heat shock at 42 °C for 40-45 minutes and maintained
by crossing with hermaphrodites. Self-fertilized hermaphrodites can lay approximately
300 eggs and the number can be above 1, 000 when fertilized by a male [12].
At 20 °C, C. elegans has an average life span of 2-3 weeks, and it needs around 14
hours, 12 hours, 8 hours, 8 hours, 10 hours, and 8 hours respectively to grow up from
embryo, L1, L2, L3, L4-young adult to adult worm. In some extreme environments, such

Fig 2. Life cycle of Caenorhabditis elegans grown at 25°C on agar plates seeded
with Escherichia coli. Eggs are laid ∼5 h after fertilization, and hatching occurs ∼9 h later
growing up from L1 to L4 in normal condition. L1 Larva can become dauer larva in extreme
environment and develop to be L4 larva after the stresses disappear. (From Jorgensen and
Mango [4], with permission from Nature Reviews Genetics, copyright 2002 Macmillan
Magazines Ltd.)

as food limitation, L1 larva can enter the dauer stage in which animals can survive
without food for several months. After the stresses disappear, the dauer larva can directly
develop into L4 larva [13, 14].
2

The genomic sequence of C. elegans was sequenced and published in 1998 with the
remaining gaps being finished by 2002 [15]. The C. elegans genome sequence is
approximately 100 million base pairs long and encodes around 20000 genes [10].

1.2 C. elegans as model organism for research
The establishment of Caenorhabditis elegans as a model system for fundamental
biological research began in 1963 by Sydney Brenner in Cambridge. In a letter to Max
Perutz, Brenner states that “future of molecular biology lies in the extension of research
to other fields of biology, notably development and the nervous system.”
There are six major reasons for using C. elegans as a model organism for research. (1)
It is a small animal that contains orthologs and homologs of numerous human genes.
Thus, mechanistic studies of C. elegans genes and pathways may have direct input to our
understanding of human genes and related pathways. (2) It has very short life cycle (2day developmental process from embryo to adult), which can significantly expedite
research progresses. (3) C. elegans is very easy to maintain in the lab at low cost so even
labs with limited resources and personnel can use it for research. (4) The worm strains
can be safely stored at -80°C with freeze buffer. It is thus not necessary to maintain live
stocks in the lab. (5) Transgenic C. elegans strains can be created rapidly through
injection of target plasmid constructs into the gonads followed by picking up the
progenies with expected phenotype [16]. (6) C. elegans loss of function mutants can be
created through treatment with chemical mutagen, such as Ethyl Methanesulfonate
(EMS), or exposure to ionizing radiation, such as UV light or gamma ray [4, 17]. Genetic
backcrossing is required in the following steps to remove the undesired alleles. After
3

back crossing, the worms are allowed to self-fertilize to become homozygotes for the
target gene. At present, there is a large collection of C. elegans genetic mutants in
Caenorhabditis Genetics Center (CGC). Or you can always request mutant strains from
the labs that generated them [18].

1.3 RNA interference and gene silencing
The phenomenon of gene silencing was first described in plants by Matzke and her
colleagues. They reported that the selectable marker encoded by a transfer DNA (TDNA) became silenced upon secondary transformation using the same T-DNA [19]. In
1990, Napoli’s lab engineered transgenic plants harboring copies of flower pigmentation
gene chalcone synthase (CHS). The plants are expected to overexpress CHS and
strengthen the purple coloration in flowers. However, the transformed flowers showed
different patterns of pigmentation, including white and purple with white, suggesting
gene silencing of CHS in the transgenic plants [20]. At the same year, co-suppression
phenomenon was also observed in plants which were engineered to express virus coat
protein (CP). The transgenic plants confer resistance to corresponding virus or closely
related viral strain [21]. In another study in 1993, Linbdo and colleagues also obtained
Tobacco Etch Virus (TEV) resistance by transforming TEV sequence into the plants.
They noted that the transgenic tobacco is resistant to TEV infection but susceptible to
unrelated virus strain Potato Virus X (PVX) [22]. Their nuclear run-off analysis and
northern blot results showed that the TEV are still transcribed but mRNA cannot
accumulate, indicating that gene silencing or co-suppression occurred in cytoplasm in a
post-transcriptional manner. The important discovery from Dr. Baulcombe’s group
4

further confirmed this hypothesis. In their study, plants recovered from first infection by
Tomato black ring nepovirus (strain W22) became highly resistant to W22 when the
second infection was performed. However, the recovered plants were sensitive to
infection of PVX virus, which is unrelated to W22. To find out whether it is the sequence
similarity between W22 and PVX virus that accounts for such a phenomenon, PVX virus
was engineered to carry W22 sequences and then was used for the secondary infection
[23]. As a result, the mRNA of the modified virus failed to accumulate in plants,
suggesting the existence of sequence-specific antiviral gene silencing in a transgeneindependent manner.

1.4 RNAi and dsRNA trigger in C. elegans
Although the phenomenon of gene silencing was first found in plants, the discovery of
double-stranded RNA as trigger to induce gene silencing was made later by Andrew Fire,
Craig Mello and their colleagues by utilizing C. elegans as model organism. They found

Fig 3. Illustration of RNAi triggered by dsRNA. The difference forms of RNA were
introduced into worm gonads by injection. There is no effect while injecting sense
RNA or antisense RNA, whereas injecting double-stranded RNA induced strong
silencing of target gene.

5

that injecting sense and antisense RNA molecules encoding a muscle protein led to no
effect in the movement of C. elegans. However, the worm lost the function of the same
gene after injecting corresponding double-stranded RNA (Fig 3) [24]. They characterized
several features of the RNA interference (RNAi) phenomenon: (1) it is only induced by
dsRNA, (2) the effect of RNAi is systemic, and (3) RNAi is heritable. This discovery
significantly speeded up studies on RNAi in plants and fungi and the study on
endogenous RNAi regulated by miRNAs (microRNAs) which were discovered
previously. In the siRNA (small interference RNA) -mediated RNAi pathway, RNAi
response is triggered by dsRNA [24-27]. dsRNAs will be then cleaved by Dicer proteins
into short 20 to 30 nucleotides (nt) RNA duplex named siRNAs [28, 29]. The passenger
strand is then degraded, and the guide strand will be incorporated into the RNA-induced
silencing complex (RISC) to target transcripts through complementary base pairing,
resulting in either degradation or translation block. In some organisms, such as plants and
C. elegans, RNA-dependent RNA polymerases (RdRPs) produce secondary siRNAs to
amplify RNAi response [30-32]. Therefore, RNAi in these organisms is very efficient
despite limited amount of primary siRNA being produced. In addition, some organisms
have structure channels such as plasmodesmata in plants or protein transporter like SID-1
protein in C. elegans, leading to the RNAi signal spread from cell to cell [33, 34]. The
capability to help RNAi response spread systemically contributes to efficient antiviral
defense in the whole organism.
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1.5 Molecular mechanisms of worm RNAi
Classical RNAi is defined as initiating RNAi response using artificial double-stranded
RNA. Originally, RNAi study was conducted by injecting dsRNAs into worm gonad or
cavities to induce the phenotype in parents or progenies [24]. Later, Lisa Timmons and
Andrew Fire developed a construct which can produce dsRNA in E. coli. After they
transformed the engineered construct into E.coli and fed worms with it, the corresponding

Fig 4. Illustration of strategies for triggering RNAi in C. elegans. (A) Feeding the worms with
transgenic bacteria expressing dsRNAs to silence the corresponding gene of interest. (B)
Transgenic array producing specific dsRNAs in vivo. (C) Synthesized dsRNAs introduced
into worms through either injection or soaking. (From Jose AM and Hunter CP [35])

gene was successfully silenced [36]. At the same year, Tabara and Mello proved that
soaking worms in dsRNA is also able to trigger the silencing of homologous genes [37]
(Fig 4).
Based on these discoveries, Tabara and Mello performed large-scale random genetic
screens to look for genes required for RNAi. After mutagenesis, only RNAi deficient
mutants can produce normal brood of viable progenies while one of the genes important
7

for embryogenesis is silenced through dsRNA feeding method. The mutants identified in
this study were termed RNAi-deficient (rde) mutants [38]. Among the genes they
identified rde-1 (RNAi defective 1) encodes an Argonaute protein. rde4 (RNAi defective
4) encodes a dsRNA binding protein. Some other rde mutants, such as rde-2 and rde-3,
exhibited high rate of transposon mobilization [38].
Soon after that, the RNAi pathway was found to be conserved in diverse organisms. It
is also widely applied in identifying the biological function of genes in cell culture or in
model organisms through the RNAi-mediated “knockdown” strategy. Since RNAi may
not completely abolish the expression of target genes, multiple repeats should be done to
confirm the results.

Fig 5. Extracellular long dsRNA is taken up by the intestinal cells via SID-2 RNA
transporter. Long dsRNAs are processed into small dsRNA fragments known as primary
siRNAs by the DICER/RDE-4 complex. One of strand from primary siRNA is loaded into
RISC and guide it to its complementary targets. RdRP is recruited to generate secondary
siRNAs (22GRNAs) by using primary siRNA as primers. (From Alper Akay, Peter Sarkies
& Eric A. Miska [39])
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Classical RNAi pathway is initiated by artificial dsRNAs of C. elegans genes. In the
first step, the PAZ-PIWI family protein, RDE-1, and the dsRNA binding protein, RDE-4
(RNA defective 4), together with worm DICER, DCR-1 (an RNase III family
ribonuclease) [40] form a complex to process dsRNA into siRNAs (Fig 5) [41].
Subsequently one of the strands (anti-sense strand) is loaded into RDE-1-associated
complex, RISC. However, there are around 25 PAZ-PIWI homologs in C. elegans [38].
Most of them act as components of RISC and the functions are still unknown. Guide
strand from siRNA directs RISC to its complementary target transcripts and initiates
post-transcription silencing (Fig 5). This process can be amplified by synthesizing
secondary siRNA with the help of RNA-dependent RNA polymerase using target RNA
as template.

1.6 Gene silencing mediated by microRNAs
Discovery of classical RNAi pathway greatly facilitates the studies on endogenous
RNAi in various organisms because both classical and endogenous RNAi share some
core components such as Dicer. Loss of Dicer function results in lethality and sterility in
C. elegans [42-44]. Another example is the RDE-4, a dsRNA-binding protein. It is
required for both endogenous RNAi and classical RNAi pathway [40, 45, 46].
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Three main types of endogenous small RNAs, microRNA, endogenous small
interfering RNA (Endo-siRNA), and piwi-interacting RNA (piRNA), were found to play
important roles in development across kingdoms [47, 48]. In C. elegans, miRNAs
contribute to diverse development and physiological processes in soma cells. EndosiRNAs, also termed 22G and 26G RNAs, and piRNAs are required for germline
development, transposon control, and pseudogene control. The major role of EndosiRNAs and piRNAs is to constitute a complete, robust system for controlling

Fig 6. Biogenesis of the three endogenous classes of small RNAs. (left) endo-siRNAs can be
produced by RdRPs using mRNAs as templates, or produced by Dicer thorough cleavage of
long dsRNAs that are derived from convergent transcripts long-hairpin RNA and homologous
pseudogenes. (center) pri-miRNAs are transcribed from miRNA genes and can form stemloop structure precursors. Pri-miRNAs are sequentially processed by RNase III enzymes
Drosha and then Dicer to turn into mature miRNAs. (right) piRNAs are generated in a Dicerindependent manner from long piRNA precursors, which are transcribed from piRNA genes or
directly from piRNA cluster. piRNA is incorporated onto PIWI proteins. They can be
amplified by PIWI family Argonautes in a ping-pong mechanism. (From Cecere G and
C 2014 Elsevier)
Grishok A [5], Copyright ○

development activity of C. elegans (Fig 6).
The first type of endogenous small RNA discovered in C. elegans is the miRNA lin-4.
The study on the biological function of lin-4 suggests that small RNA can initiate post-
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transcription regulation [49, 50]. lin-4 is required for L1-L2 stage transition during
development [51]. This means that lin-4 directed worm development is to regulate lin-14,
which encodes protein required for specifying division timings. Previous studies proved
that lin-4 binds to the 3’ untranslated region (UTR) of Lin-14 with imperfect
complementarity for negative regulation [49, 52].
The second microRNA identified was let-7, whose sequence is conserved in
drosophila, zebrafish and humans. In C. elegans, let-7 controls L4-adult transition by
down-regulating lin-41, which encodes a protein required for specific postembryonic cell
fate [53, 54]. let-7 interacts with lin-41 at two sites in its 3’UTR region [54]. These let-7
complementary sites are also found in drosophila and zebrafish in 3’UTR of lin-41 [55],
suggesting this mechanism is also conserved in other animal species. Since the discovery
of the first two miRNAs, the role for miRNAs in development has been established and
more and more miRNAs were identified in C. elegans. For example, lsy-6 and mir-273
are two miRNAs involved in controlling asymmetric fates of two neurons in the head
[56]. It is important to note that miRNAs also play very important roles in mammals
because the activity of up to 30% of the proteins is controlled by miRNAs in mammals
[57]. In total, 88 validated miRNA genes are found in the C. elegans and almost half of
them are conserved in humans [58].
In C. elegans, the miRNA biogenesis begins with the transcription of primary miRNA
(pri-miRNA) by polymerase II [59]. Pri-miRNA is then cleaved by the endonuclease III
Drosha together with partner of Pasha into precursor-miRNA (pre-miRNA) [60]. The
Pre-miRNA is exported from the nucleus to the cytoplasm in an exportin-5-proteindependent manner [61]. The stem-loop pre-miRNA is then processed by the RNase III
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protein Dicer in cytoplasm, generating a short imperfect double-stranded miRNA duplex.
One of the strands is selected and incorporated into RISC [62], which is a complex
containing the Argonaute family protein [63].

1.7 RNAi and antiviral immunity in diverse organisms
Viruses are formidable pathogens for all living organisms. These intracellular
pathogens interact with their host cells and hijack the machineries for replication. As a
result, hosts evolve resistance pathways against viruses.
Antiviral defense is one of the natural functions of RNA interference [64-67]. In
insects, it is known that RNAi is the major antiviral pathway that contains Dicer, DCR-2
and Argonaute protein family. In insects several viral recognition and antiviral signaling
pathways have been identified. For instance, insects have three orthologues of eIF2α
kinases, which control translation initiation of viral replication in mammals. As another
example, the JAK/STAT and Toll signaling pathway are found to have antiviral activity
in insects. These two signaling pathways are used to transmit signals to the nucleus,
leading to the expression of proteins against virus [68, 69]. Another strategy in insects to
control the viruses is cell death, which prevents virus from spreading out by killing virusinfected cell.
Fungi have evolved essential antiviral mechanism mediated by RNAi. Fungi have two
Dicer-like proteins (DCL-1/2) and three Argonaute proteins (QDE-1/2/3). Virus-derived
dsRNA can trigger RNAi response under the control of Argonaute protein QDE-2 and
DCR-2, together with other homologs of antiviral genes [70].
In plants there are four Dicer-like (DCL) proteins. MicroRNAs are predominantly
generated by DCL1, whereas DCL4, DCL2 and DCL3 produce three classes of
12

endogenous siRNAs. In plants antiviral defense against RNA viruses are also processed
by DCL4, DCL2 and DCL3. Viral double-stranded RNA are cleaved by these DCL
proteins into primary 21 to 24 nt virus-derived small interfering RNA (viRNA) based on
viral structure in a hierarchical manner [66, 71, 72]. Plant Argonaute proteins also
participate in antiviral RNAi. Previous study showed that AGO1, AGO2 and AGO7
appear to contribute to RNAi-mediated antiviral responses [73-76]. Plant AGOs associate
with viRNAs to target complementary viral RNA. The AGOs can initiate viral RNA
degradation in three ways. The first is through their slicer activity or translational arrest
of AGOs. The second is to transcriptionally repress viral gene expression by DNA
hypermethylation (For DNA virus) [77]. The third is to promote host gene expression for
viral defense [78]. In addition to primary viRNAs processed by DCLs and AGOs, RdRPs
are able to amplify plant antiviral response by producing viral secondary siRNAs [79-81].
In vertebrates, dsRNA and siRNA are known to initiate the transcription-based
antiviral interferon (IFN) response [82, 83]. At the beginning, viral ssRNA (single
stranded RNA) and dsRNA is recognized by viral sensors such as Toll-like receptor,
RIG-I (retinoic acid inducible gene I)-like receptor and the dsRNA-dependent protein
kinase R (PKR). The binding between viral sensor and virus dsRNA leads to activation of
the IFN-regulatory transcription factors (IRF) and NF-κB. As a result, IFNs expression is
activated. IFNs then give rise to the transcription and expression of IFN-stimulated genes
(ISGs) through the JAK-STAT signaling pathway for antiviral activity [82, 84-86].
Although some recent studies demonstrated that RNAi in nascent mammalian cells has
potential activity against RNA viruses, IFN response is still believed to play the major
role in antiviral defense in vertebrates [9].
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1.8 Current understanding of antiviral RNAi in C. elegans
C. elegans has been shown to be an ideal model to study RDVI (RNAi-derived Viral
Immunity). More importantly, RNAi is the major antiviral defense for C. elegans, making
the study of RDVI mechanism much easier and straight-forward compared to other
organisms such as insects and mammals, in which multiple antiviral pathways co-exist.
In C. elegans, infecting viruses, usually single stranded, generate long dsRNAs during
replication. In plants and invertebrates, Dicer cuts viral dsRNAs into small fragments of
viRNAs, which are structurally similar to the siRNA duplex intermediate [64]. This
process is conducted by DCR-1, the only Dicer protein in C. elegans. Afterward, one of
the strands, termed as guide strand, from the viRNA duplex is loaded into RISC and used

Fig 7. Schematic pathway of RDVI. Under the low concentration of viral dsRNA, viral
dsRNAs are more likely to be detected by DRH-1 and RDE-4 and cleaved by DCR-1. When
the viral dsRNA concentration is very high, the viral dsRNA can be processed by DCR-1 in
the absence of RDE-4. The subsequent processes are the same. One of the strand from
primary siRNA, guide strand, will be loaded into RDE-1 complex as a sequence guide to
target viral mRNA. This process can be amplified by producing secondary viRNAs with
RRF-1 (RdRP), DRH-3 and RSD-2. Secondary viRNAs bind to secondary WAGO to initiate
the cleavage of viral mRNAs.
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as reference to target viral transcripts through complementary base pairing, leading to the
silencing of viral gene expression [87]. In some organisms, such as plants and nematodes,
the production of secondary siRNAs generated by RdRP amplifies antiviral RNAi
process by engaging the secondary worm-specific AGO (WAGO) proteins [80, 88].
Our studies suggest that RDVI can proceed in two pathways. One is RDE-4 dependent
pathway which defends against low concentration of viral dsRNA. The other one is RDE4-independent pathway when high concentration of viral dsRNAs are produced in the
organism (Fig 7). In these two pathways, the downstream processes following the
production of primary siRNA are believed to be the same. One of the crucial domains of
RDE-1 has an RNase H like activity that performs a cleavage on the target RNA
molecule [89, 90]. However, the “slicer” activity from RDE-1 is unlikely to cleave
mRNA, but to cleave primary siRNA duplex [91]. During the amplification process,
recruitment of RdRP (RRF-1) initiates the de novo synthesis of secondary viRNAs using
the viral mRNA as template [7]. In the meantime, RSD-2 (RNA spreading defective 2）
and DRH-3 are also involved in maintaining the functionality of secondary viRNAs [92].
Unlike primary siRNAs, secondary siRNAs are single-stranded and contain a
triphosphate group at the 5’ end [31, 32]. These secondary siRNAs bind secondary
WAGO proteins and destroy viral RNAs through an unknown mechanism [93].
Detailed information about the genes associated with known antiviral RNAi pathway
in C. elegans is presented below.
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1.8.1 The drh-1 Gene
DRH-1 (Dicer-related helicase 1), RNA helicase-related protein, was first found in a
protein complex with RDE-4, DCR-1, RDE-1 in vivo. DRH-1 is not required for classical
RNAi since drh-1 mutant is still sensitive to RNAi feeding.
C. elegans encodes a family of Dicer Related Helicases (DRH), including DRH-1,
DRH-2 and DRH-3. They all contain a DExD/H box RNA helicase domain highly
homologous to DICER and the mammalian RIG-I-like RNA helicase (RLH) family
composed of RIG-I, MDA5 and LGP2 [6, 27, 28]. These RLH proteins possess the ability
to recognize nucleic acid signatures from virus and initiate activation of antiviral
signaling pathway.
There are no developmental abnormalities observed in drh-1 mutants. In recent study,
DRH-1 was shown to function in RNAi-mediated antiviral immunity in C. elegans. It
encodes the helicase and C-terminal domains homologous to the mammalian RIG. It is
been reported that the complete antiviral function of DRH-1 requires both RIG-I
homologous domains as well as its worm specific N-terminal domain [94]. In addition,
C-terminal domain and helicase domain encoded by human RIG-I can functionally
substitute corresponding domains in DRH-1 [3]. What’s more, northern blot and small
RNA deep sequencing analysis indicate that DRH-1 acts to enhance production of viral
primary siRNAs but not secondary siRNA [3]. These results thus revealed that DRH-1
plays an essential role in antiviral defense mechanism mediated by RNAi. Similar to
human RIG-I, DRH-1 is very likely to function as viral sensor and facilitate acquisition
of viral dsRNA. Interestingly, another study from Dr. Ding’s lab suggested that DRH-1
may facilitate the biogenesis of viRNAs by catalyzing translocation of the Dicer complex
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on the viral long dsRNA precursors. Their hypothesis is based on different distribution of
viRNA “hot spots” in between drh-1 mutants and wild type animals [95].

1.8.2 The rsd-2 Gene
RSD-2 is a novel protein with no close homologs in other species. Originally, rsd-2
was identified as a gene required for RNAi spreading from somatic cells to germline cells
in C. elegans. rsd-2 mutants show no developmental defects [96]. Studies have shown
that rsd-2 mutants displayed a phenotype when fed with dsRNA against somatic genes,
but not germline genes [96]. These findings indicate that rsd-2 mutants are sensitive to
RNAi against somatic genes, but not to RNAi targeting germline genes. In other words,
mutations in the rsd-2 gene do not affect somatic RNAi [96].
Later on, it was discovered that the function of rsd-2 in RNAi is very complex and
environment-related. Firstly, rsd-2 gene mutants are mosaic with respect to somatic
RNAi and germline RNAi based on the observations that some of the cells are RNAi
defective (somatic and intestine) but some are not (germline). Secondly, the rsd-2
mutants show environmentally sensitive defects. For example, temperature sensitivity.
Moreover, rsd-2 mutants have a dosage-sensitive nature, in other words, higher dosage of
dsRNA can elicit better RNAi response in rsd-2 mutant. Additionally, rsd-2 also plays an
important role in chromosome integrity, such as transposon silencing [67].
The rsd-2 gene is located on chromosome IV and is predicted to encode three copies of
N-terminal domain at the N terminus [96]. RSD-2 protein was found to exist in multiple
cellular compartments, including the nucleolus and cytoplasm, and to most frequently
interact with RSD-6 [67]. It is known that RSD-2, RSD-6, and HAF-6 are all required for
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accumulation of X-cluster (a region of the X chromosome from which abundant 22Gs)
22G RNAs [97], suggesting a critical role in WAGO 22G RNA accumulation or function.
Study from our lab also demonstrate that rsd-2 is responsible to biogenesis of secondary
viRNAs [7].

1.8.3 The rde-1 Gene
The rde-1 gene was identified in a large-scale genetic screen. Several other rde
mutants such as rde-4, rde-2 and rde-3 were also identified in the same genetic screen
[37].
rde-1 is a member of the AGO gene family conserved in numerous organisms.
Members of the AGO family are involved in developmental pathways in insects, fungi,
plants and animals. RDE-1 is composed of four domains: A N-terminal domain, a PAZ
domain binding to 3’ of guide RNAs, a MID domain forming the structure for 5’ of guide
RNA binding, and a piwi domain with endo-nucleolytic activity [98]. It is known that
RDE-4 interacts with RDE-1 and DRC-1 in the exogenous RNAi pathway. The
interactions among these proteins result in a transfer of siRNA from RDE-4/DCR-1
complex to RISC containing RDE-1 [40]. However, Secondary 22G siRNAs are rarely
bound to RDE-1. Instead, they tend to bind to WAGO Argonautes.
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1.8.4 The rde-4 Gene
RDE-4 interacts with dsRNA in vitro and in vivo. The RDE-4 protein contains two
copies of dsRNA binding motif (dsRBM) that is also found in numerous other proteins.
The dsRBM interacts with dsRNA in a sequence-non-specific manner [99]. In reciprocal
assays, RDE-1 and RDE-4 were found to co-precipitate, suggesting a stable interaction
between RDE-4 and RDE-1 in vivo. RDE-4 protein also interacts in vivo with DCR-1 and
a conserved DExH-box helicase DRH-1 [40].

Fig 8. Northern blot analysis of viRNA in different antiviral RNAi defective mutants under
long exposure (upper) and shorter exposure (bottom). No viRNAs were detected in drh-1 and
rde-4 mutants. In comparison, viRNAs accumulation are found in both rde-1 and drh-3
mutants. ( From Guo and Lu [7])

Previous study showed that DRH-1 and RDE-4 function in the upstream of the
initiation of RNAi (Fig 8) [100]. RDE-4 does not appear to interact with mRNA or
siRNA. The RNA sequence bound to RDE-4 are strictly within the dsRNA trigger [40].
The interaction between RDE-4 and Dicer in the RDE-4 immune complex allows RDE-4
to present the foreign trigger dsRNA to DCR-1 for processing [40].
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1.8.5 rrf-1 and drh-3
rrf-1, which encodes an RNA-dependent RNA polymerase, is responsible for most of
the RdRP activity in exogenous RNAi in somatic cells [88]. DRH-3, a worm RIG-I like
homolog shares a similar domain structure with DRH-1 but confers distinct function. In
northern blot assay (Fig 8) and deep sequence results (Fig 9) of viRNAs, rrf-1 and drh-3

Fig 9. The size distribution of virus-derived reads in rrf-1 and drh-3 mutant. Distribution of
reads reveals a strong read bias at 23 nt length in both rrf-1 and drh-3 mutant worms. (From
Guo and Lu [3])

mutants produced a typical 23 nt length population of primary viRNAs, but not 22 nt
secondary viRNAs. These results strongly suggested that these two genes are required for
the biogenesis of secondary viRNAs, but not primary viRNA. Therefore, both rrf-1 and
drh-3 contribute to antiviral RNAi in the amplification stage. They play an important role
in biogenesis and functionality of viral secondary siRNA.

In our study, drh-3 and rrf-1 mutants were used to check whether the transgenic array
we developed can influence virus replication in the absence of rrf-1 or drh-3.
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1.9 Objective of my research
The aim of my study is to better understand how RNAi regulates virus-nematode
interactions using C. elegans as a model system. Previously random large-scale genetic
screens have been carried out to identify genes involved in classical RNAi [38].
However, the genes that specifically contribute to antiviral defense cannot be discovered
this way. For example, drh-1, a gene not required for classical RNAi, was discovered

Fig 10. The structure of transgene array. The transgene array includes Psur-5::rde1::UTR,
Psur-5::rde4::UTR, Psur-5::drh-1::UTR, Psur-5::rsd-2::UTR, HIP::RdRP::GFP and
Pmyo2::mCherry::UTR. Psur-5, the promoter for the endogenous gene sur-5; rde-1, the
coding sequence of wild-type rde-1; rde-4, the coding sequence of wild-type rde-4; drh-1, the
coding sequence of wild-type drh-1; rsd-2, the coding sequence of wild-type rsd-2; UTR, the
3’-end untranslated region of unc-54; Pmyo2, a pharyngeal muscle promoter which can only
drive mCherry expression in head; HIP, Heat-induced promoter. GFP, green fluorescence.

through biochemical approach. By using modified-virus as a reporter of loss of RNAi, we
are expecting to identify genes involved in both classical RNAi and antiviral RNAi.
C. elegans genome encodes RdRPs as do plant genomes. Like mammals the worm
genome also encodes a single Dicer. Thus, findings from my study are expected to have
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direct input to the study of RDVI in diverse organisms. My study on the function and
mechanism of worm-specific genes is also expected to unravel some novel features of
worm RDVI.
Currently, it remains unclear whether RDVI in C. elegans requires novel genes.
Apparently, identification and function characterization of novel RDVI genes will allow
us to gain further insight into the mechanistic basis of antiviral RNA silencing across
kingdoms. Recently, RNAi as an antiviral mechanism was found to be active in
pluripotent mammalian stem cells and essential for developing mice to fight against virus
infection. Thus, a better understanding of worm RDVI may facilitate the development of
novel therapeutic strategies for the treatment of human diseases caused by viral infection.
To identify novel genes involved in worm RDVI, we developed a unique reporter
worm strain termed 48 that contains a viral reporter and four known antiviral RNAi
genes. I mixed 6 plasmid constructs, corresponding to Pmyo-2::mCherry::UTR,
HIP::FR1gfp, Psur-5::drh-1::UTR, Psur-5::rde-1::UTR, Psur-5::rde-4::UTR, and Psur5::rsd-2::UTR respectively (Figure 10), and injected them into rde-1;rde-4 double
mutants that already contain an HIP::FR1gfp-derived transgene. The viral reporter
transgene array will produce green fluorescence upon the loss of antiviral RNAi. In C.
elegans, transgenes generated through gonad microinjection often exist in multiple
copies. Thus, a genetic screen utilizing 48 as reporter will be unlikely to provide hits to
any of those four known antiviral RNAi genes because of the redundant copies for each
gene. We expect that a large scale genetic screen utilizing the 48 worms as reporter will
lead to rapid identification of novel genes with dedicated function in worm RDVI.
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CHAPTER 2: MATERIALS AND METHODS
This chapter describes the materials and experimental protocols in this study. Sample
volumes up to 2.0 mL were centrifuged in Micro-Centrifuge Tubes with
graduations(VWR), sample volumes from 2.0-14 mL were centrifuged in 14 ml
Polypropylene Round-Bottom Tube (BD Falcon). Sample volumes larger than 14 ml
were all centrifuged in 50mL Centrifuge Tube (Cristalgen).

2.1 Materials
2.1.1 Worm Strains
Caenorhabditis elegans strains used for the study:
N2, wild type of C. elegans was used as a reference strain in this study. N2 line is
derived from the Bristol culture in the spring of 1964.
All other strains used in this study are derived from N2 and include rde-1(ne300), rde4(ne337), rsd-2(pk3307), drh-1(tm1329), rrf-1(ok589), drh-3(ne4253).
rde-1 (ne300) has a single nucleotide substitution causing a premature stop codon prior
to the most conserved region within K08H10.7 product.
rde-4 (ne337) contains a nucleotide substitution which induces a premature stop codon
at amino acid residue 229 of the T20G5.11 product.
rsd-2 (pk3307) contains a point mutation at position 13832 in chromosome IV (C to T)
which induces a premature stop codon.
drh-1 (tm1329) has 483bp insertion at position 10039 and a 13bp insertion on
chromosome IV.
rrf-1 (ok589) is a deletion allele which contains 910bp deletion that affect coding exon
and intron.
23

drh-3 (ne4253) is a single base transition (C to T) at position 3896 on chromosome creating
an early stop codon.

The genotypes of rde-1, rde-4 and rsd-2 were confirmed by skn-1 feeding RNAi
together with DNA sequencing. The genotype for drh-1 was confirmed by PCR. The
worms were maintained in NGM (nematode growing medium) seeded with OP50
bacteria. 48 transgene array and 11 transgene array were delivered into various genetic
backgrounds by standard genetic cross. 46 transgene array was integrated onto genome of
11/N2 background and then introduced into other different genetic backgrounds by
standard genetic cross. All the worm strains are grown up at 20-22℃.

2.1.2 Bacteria strains
All feeding plates were seeded with bacterial strains, derived from HT115 (DE3),
engineering to express double-stranded RNAs corresponding to target genes [101, 102].
This RNase III-deficient strain has an IPTG inducible gene which encodes T7 RNA
polymerase. Because the DNA sequence is inserted between two T7 RNA polymerase
promoters in the plasmid, the binding of T7 RNA polymerase to T7 promoters leads to
the transcription of dsRNA from two strands of insert [103]. The vector is marked with
Tetracycline resistance[104].
To introduce RNAi by feeding with dsRNA-expressing HT115, worms at L1 or L2
larvae stage were transferred onto freshly prepared feeding plates.
DH5α competent cells are used for general cloning. The cells are defined by three
mutations recA1, endA1 which help plasmid insertion and lacZM15 that help to enable
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blue white screening. Calcium chloride are often used to help transform plasmids into the
cell.
Plates containing OP50 food were used as control in each experiment. E. coli OP50 is
an uracil auxotroph whose growth relies on the nutrients of NGM plate. The limited
bacteria growth is desirable because it can offer easier observation and operation.
All the bacteria were grown at 37℃ overnight. Liquid cultures were grown in a shaker
at 180 RPM (NEW BRUNSWICK SCIENTIFIC).

2.1.3 Virus

There are two viruses included in our study, Flock House Virus (FHV) and Orsay
virus.
FHV is a positive-stranded RNA virus isolated from Costelytra Zealandica (white).
The FR1gfp replicon (HIP::RdRP::GFP) was developed from flock house virus (FHV)
RNA1 by replacing the coding sequence of B2, the FHV-encoded RNAi suppressor, with
green fluorescence protein (GFP) sequence.
Orsay virus is a positive single-strand RNA virus that naturally infects C. elegans
nematode. The virus was discovered in rotting fruit in Orsay, France. The virus was
maintained in worm strain JU1580.

2.1.4 Transgene construction
All plasmids constructed for constitutive expression of the target genes were based on
the PD51 vector described previously. Transgene array including Psur-5::rde1::UTR,
Psur-5::rde4::UTR, Psur-5::drh-1::UTR, Psur-5::rsd-2::UTR, HIP::RdRP::GFP,
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Myo2::Mcherry::UTR. Psur-5, the promoter for the endogenous gene sur-5; rde-1, the
coding sequence of wild-type rde-1; rde-4, the coding sequence of wild-type rde-4; drh1, the coding sequence of wild-type drh-1; rsd-2, the coding sequence of wild-type rsd-2;
UTR, the 3’-end untranslated region of unc-54. It is noted that besides Psur-5::rde1::UTR
and Psur-5::rde4::UTR, the other four constructs (Psur-5::drh-1::UTR, Psur-5::rsd2::UTR, Pmyo2::mCherry, HIP::FR1gfp) are already available in our lab before this
project.

2.1.5 Nematode growth media (NGM) plates and LB agar plates
NGM plates preparation starts with making potassium phosphate (PPK) buffer prior to
making NGM plate by mixing 132 mL of K2HPO4 (1 M) with 868 mL of KH2PO4 (1
M). For 1 liter of NGM, dissolve 2.5g NaCl, 3g bacto peptone and17 g/L agar in 975 ml
purified water. After autoclaving, add 1mL 1M CaCl2, 1M MgSO4, 0.5 ml 10mg/ml
cholesterol, 25 mL PPK and 15 mL 2g/L Uracil when the agar cools to around 65℃.
LB agar plates were prepared by mixing 20/L Agar, 10g/L Tryptone, 10g/L NaCl and
5g/L Yeast Extract. Add 1L deionized water and sterilize by autoclaving. Add 100 µg/mL
ampicillin if needed when agar is cooled to 50 ℃.

2.1.6 Imaging Microscopy
GFP fluorescence images were collected using an AmScope MT1000 camera mounted
on an Olympus IMT-2 microscope.
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2.2 Method
2.2.1 Infectious Filtrate Preparation and Orsay Virus Inoculation
Orsay virus was maintained using the JU1580 strain at 20℃ feeding on normal OP50
E. coli bacteria. To prepare infectious Orsay virus filtrate, infected JU1580 worms were
washed off from 10 cm plates using autoclaved distilled water. The virus-containing
liquid was then filtered through 0.22-μm filter units and mixed with OP50 culture or
other H115-derived strains for NGM plate seeding.
2.2.2 Transgenic Construct and Transgenic Worms
To develop such a reporter worm strain, I mixed 6 plasmid constructs, corresponding
to Pmyo-2::mCherry, HIP::FR1gfp, Psur-5::drh-1::UTR, Psur-5::rde-1::UTR, Psur5::rde-4::UTR, and Psur-5::rsd-2::UTR respectively（developed from PD51 vector）,
and injected them into rde-1;rde-4 double mutants that already contain an HIP::FR1gfpderived transgene (developed from PPD49_83 vector by Fire Lab C. elegans Vector Kit
1995). The Pmyo-2::mCherry-derived transgene is expected to direct mCherry expression
only in the head of transgenic worms, and thus will serve as selection marker for the
transgene array to be created. The HIP::FR1gfp-derived transgene will serve as viral
reporter in this study as it will initiate virus replication and GFP production upon heat
induction. Transgenes derived from the other four constructs will direct the expression of
drh-1, rde-1, rde-4 and rsd-2 respectively. Heat induction was performed at 33℃ for 3
hours. The heat induced plates were then incubated at 25℃. Assays were performed 24 to
48 hours post heat induction.
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2.2.3 Microinjection
Microinjection is an effective method to create transgenic strain in worm system. Since
the distal gonad of C. elegans contains a central core of cytoplasm that is shared by many
germ cell nuclei. Therefore, delivering DNA at this position will have the most chance to
generate transgenic progenies. The extrachromosomal DNA arrays usually form by using
this technique. I use capillary tube and pull needles for microinjection. The final
concentration of DNA injection mix should be 200 ng/µL (60% 1kb DNA ladder, 10%
reporter gene, 10% transgene, 20% PUC18 vector). Centrifuge DNA mix for 10 min at
max speed. This pellets any dust particles in the tube, which may block the needle. Load
1 µl of DNA injection mix to the unpulled end of capillary tube and wait for at least
10min until all the DNA solution move to the tip of the needle. Break a small opening of
the needle by gently hitting the needle to a capillary tube. Lay C. elegans on agarose pad
and cover them with microinjection oil to prevent them from dehydration. Find the gonad

Figure 11. Microinjection of the C. elegans gonad. The optimal position of the injection
needle in the cytoplasmic core of the distal germ line is depicted. For DNA transformation,
injection solution should flow in both directions through both the distal and proximal germ
line (arrows). (From Thomas C. Evans [2])

of C. elegans, position the worm at the orientation of 30ºto 45ºtowards the needle. Insert
the needle into the worm gonad and inject DNA solution (Fig 11).
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2.2.4 Transformation
2.2.4.1 Preparation of competent cell

Grow up the cells (DH5α, HT115) on the LB plates at 37oC overnight. Place one
colony in 500ml LB media and grow overnight at 37 oC. Stop incubation when the E. coli
is at an OD600 between 0.4 and 0.6 and place it on ice. Transfer cells to centrifuge bottles
and centrifuge at 4 oC for 3500rpm for 15 mins. Discard supernatant and resuspend in
0.1M CaCl2 and 15% glycerol. Cells must remain cold in all the procedures. The
competent cells were stored at -80oC in 100 µl aliquots.

2.2.4.2 Transformation
Mix 10pg-150ng DNA with 100 µl competent cells, and incubate on ice for 30 mins.
Heat shock at 42 oC for 45 secs and then place cells on ice for 5 mins. Then suspend the
competent cells with 400 µl of LB media and incubate in a shaker at 37 oC at 180rpm for
45 mins. Place the cells on LB plates containing antibiotics and allow it to grow up at 37
o

C overnight. Only transformed cells can survive the next day.

2.2.5 Plasmid extraction
DNA plasmid extraction method is modified based on protocols from QIAGEN
plasmid kit. Harvest bacterial culture (100 mL) overnight at 37 oC. Centrifuge bacteria at
3500rpm for 15 min. Discard supernatant and resuspend the bacterial pellet in 4 ml buffer
P1. Add 4 ml Buffer P2, invert to mix and incubate at room temperature for 5 min. Add 4
ml Buffer P3, mix well and incubate on ice for 15 mins. Transfer the solution into 14 ml
falcon tube and centrifuge at 5000rpm for 30 mins. Equilibrate QIAGEN-tip with 4 ml
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QBT and allow the column to empty by gravity flow. After centrifuge the bacterial
solution, transfer the supernatant of bacterial solution to QIAGEN-tip and let it flow
through the column. Wash the QIAGEN-tip with 10 mL buffer QC two times. Elute DNA
with 5 ml Buffer QF and add 3.5 mL of isopropanol for precipitation. Centrifuge at
14000rpm for 30 min at 4 oC and a white pellet is expected to form at bottom of tube.
Wash the DNA pellet with 2 ml of 75% ethanol and centrifuge at 14000 rpm for 5 mins.
Air dry the pellet for 5-10 mins and dissolve DNA with appropriate volume of pH 8.0 TE
(Tris-EDTA) buffer.

2.2.6 RNA Extraction
Wash worms off plates with M9 buffer or RNAase free water and collect them in 15ml Corning tubes. Wash 2 – 3 times to get rid of bacteria. Add 1ml Trizol reagent and use
homogenizer to break C. elegans. Add 0.2 volume of chloroform and Invert 5-6 times,
and let sit 2-5 min at RT (room temperature) for phase separation. Transfer the solution
into phase-lock gel tube and Spin 15 min at 12,000 x g at 4 °C. RNA is in the aqueous
supernatant. Transfer top supernatant to new RNase-free tube. Add 0.7 volume of
isopropanol (typically 500 µl). Gently invert several times to mix. Store at -20°C for 30
min. Spin at 12,000 x g for 15 min at 4 °C. A white RNA pellet at the bottom of tube
should be visible. Carefully discard supernatant and wash pellet once with 75% EtOH.
Spin 8500 rpm at 4 °C for 5 min. Discard EtOH and air dry the tube for 5-10 min. Dilute
2 µl of RNA sample in 98 µl RNase-free water. Take 260/280 nm and 260 nm absorption
reading.

30

2.2.7 DNA Extraction
Grow worm strains on NGM plates seeded with OP50 bacteria. Wash the worms from
the plate with autoclaved water and pellet the worms by spinning at 3500 rpm for about 1
minute. Aspirate off supernatant and repeat washing several times if needed. Flash freeze
pellet in liquid nitrogen or -20°C freezer for 20 mins. Add five volumes of worm
genomic DNA lysis buffer with proteinase K (0.1mg/mL) and incubate at 65 oC for 1-2
hours. Deactivate proteinase K at 95°C for 20 minutes. Add RNase A to 0.1mg/mL and
incubate at 37 oC 1 hour. Add 1 volume of tris-buffered phenol. Mix gently and spin at
4,000 rpm for 5 minutes at room temperature. Transfer the aqueous phase to a new tube
(Note: avoiding the phenol phase and interface). Extract once with 1 volume
phenol/chloroform/isolamyl alcohol (25:24:1, v/v) and then with chloroform/isoamyl
alcohol (24:1, v/v). Add 0.6 volume of -20°C isopropanol and thoroughly mix by
inverting. The white DNA pellet should be visible after spinning 12000 rpm at 4°C for 5
minutes. Wash once with 70 % EtOH and air dry at room temperature for 5-10 minute.
Then resuspend genome DNA pellet in proper volume of ddH2O or TE. Take OD
readings at 260nm (nucleic acids).

2.2.8 Genome DNA shearing
The DNA was sheared using a biorupter (15secs on, 90 secs off, for 9 minutes). To
construct six libraries (five candidate libraries and one control library) for sequencing, 1
µg from each pool was used to generate a library using the PCR-free Truseq DNA kit
(Illumina).
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2.2.9 Polymerase chain reaction (PCR)
2.2.9.1 Phusion High-Fidelity PCR

The 50 µl reactions of Phusion High-Fidelity PCR contains 10 µl 5X Phusion HF
Reaction Buffer, 1 µl 10mM dNTP, 2.5 µl 10 µM Forward Primer, 2.5 µl 10 µM Reverse
Primer, 10-1000 ng Template DNA, 1.5 µl DMSO, 0.5 µl Phusion DNA Polymerase and
Nuclease-Free water. Cycling conditions start with initial denaturation at 98°C for 30
secs and are followed by 30 cycles of polymerase chain reaction: 98 °C 10 secs, 60°C 30
secs and 72°C with extension time of 1 kb per 15-30 secs. Phusion PCR is performed in
either a DNA thermal cycler C1000 Touch (Bio-rad) or C1000 (Bio-rad).

2.2.9.2 One Taq PCR

The 50 µl reactions of One Taq PCR contains 10 µl 5X one Taq Standard Reaction
Buffer, 1 µl 10mM dNTPs, 1 µl 10 µM Forward Primer, 1 µl 10 µM Reverse Primer, 0.3
µl One Taq DNA Polymerase, 10-1000ng Template DNA and Nuclease-Free water.
Cycling conditions start with initial denaturation at 94°C for 30 secs and are followed by
polymerase chain reaction for 30 cycles: 94 °C for 30 secs, 60°C for 45 secs and 68°C
with extension time of 1 kb per min. PCR is performed in either a DNA thermal cycler
C1000 Touch (Bio-rad) or C1000 (Bio-rad).

2.2.9.3 Colony PCR

Colony PCR was used to identify colonies that contains recombinant plasmids. The
PCR was based on One Taq PCR described above but substitute template with bacterial
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cells. The thermal cycling conditions was changed by adding 2 mins of 94°C condition at
the beginning.

2.2.9.4 RT-PCR

RT-PCR was performed in two steps. Reverse Transcription (RT) was conducted by
using ProtoScript II Reverse Transcriptase. First, denature sample RNA/Primers (10 µl
volume contains 100ng-1 µg total RNA, 2 µl d(T)23VN (50 µM),1 µl 10mM dNTP and
nuclease-free water) for 5 minutes at 65°C. Then add 4 µl 5X ProtoScript II Buffer, 2 µl
0.1M DTT, 1 µl ProtoScript II RT (200 U/µl), 0.2 µl RNase Inhibitor (40 U/µl) and 2.8
µl nuclease-free water. Incubate the reaction at 42°C for 1 h and inactivate the enzyme at
65°C for 20 mins. Then use 1/10 of the products as template for Phusion PCR.

2.2.10 PCR product purification
PCR purification is performed with QIAquick PCR Purification kit. Five volumes of
Buffer PB are added to 1 volume of PCR products and mix. If the color of the mixture is
orange, add 10 µl 3M, pH 5.0, sodium acetate to the solution and the mixture will turn
yellow. Transfer the solution into QIAquick column and centrifuge for 1 min at 12000g.
Wash column with 750 µl Buffer PE and centrifuge for 1 min at 12000g. Discard flowthrough and centrifuge 1 min to remove residual PE Buffer. Place QIAquick column in a
clean 1.5 mL microcentrifuge tube and elute DNA with 35-50 µl Buffer EB. Let the
column stand for 1 min and then centrifuge at 12000g for 1 min to get purified DNA
sample.
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2.2.11 DNA Digestion
Add 20 µl DNA (Plasmid vector or insert from PCR product), 5 µl 10X cutsmart
buffer, 2 µl restriction enzyme and 23 µl sterile water and incubate at 37 °C for 3 hours.
Stop digestion by heat inactivation at 65°C for 15 mins. The buffer added is according to
NEBuffer Activity Chart for Restriction Enzyme.

2.2.12 DNA ligation
Ligations can be done at room temperature (20-25°C). For cohesive ends, use 1 µl of
T4 DNA ligase 2 µl 10X T4 DNA ligase buffer, 50ng vector DNA (0.020pmol),
37.5ng(0.060pmol) insert DNA and nuclease-free water for 20 µl reaction. Incubate at
room temperature for 1 hour or place it at 4°C overnight.

2.2.13 Gel extraction
Gel extraction is performed with QIAquick Gel Extraction kit. Add 3 volumes of
Buffer QG to 1 volume of gel and incubate at 50-60°C for 10 min until the gel slice is
completely dissolved. If the color of the mixture is orange, add 10 µl 3M, PH 5.0, sodium
acetate to the solution and the mixture will turn yellow. Add one volume of isopropanol
to the solution and mix thoroughly. Transfer the mixture into QIAquick spin column and
centrifuge for 1 min at 12000 x g. Wash column with 750 µl Buffer PE and centrifuge for
1 min at 12000g. Discard flow-through and centrifuge 1 more min to remove residual PE
Buffer. Place QIAquick column in a clean 1.5 mL microcentrifuge tube and elute DNA
with 35-50 µl Buffer EB. Let the column stand for 1 min and then centrifuge at 12000g
for 1 min to get DNA sample.
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2.2.14 Gel electrophoresis of nucleic acids
Negatively charged DNA can move on the agarose gel by electrophoresis. The agarose
gel contains 1 x TBE buffer (90mM Tris Base, 2mM EDTA). 0.1 µl ethidium bromide
and 1% agarose. 6 X Gel loading dye was mixed with DNA samples before loading into
the slots. The 1 kb DNA ladder was used as molecular size marker.

2.2.15 Northern Blot
Use gel apparatus designated for RNA. Wipe apparatus with “RNase Away”. Make 1%
Agarose gel (100ml) which contains 73 ml sterile water,1 g agarose, 10 ml 10X MOPS,
17 ml 37% Formaldehyde and Boil them in microwave for 3 min. Prepare 8 µg of RNA
for each sample. Add loading dye and formamide to make the final volume to 20 µl. Run
gel electrophoresis for 2 hours at 100V. Cut Amersham Hybond-N+ membrane (GE
Healthcare Life Science) to the size of gel. Soak Hybond-N+ membrane in 5 X SSC.
Place gel on the membrane and use vacuum blotting. The RNA samples on the gel were
then transferred to Hybond-N+ with vacuum pump for 2.5h. Then crosslink RNA to blot
with UV using Stratalinker on energy mode at 1800mJ/cm2. Prehybridize blot at 55°C
for 1 hour in Hybridization Solution (4% blocking reagent, 0.5M sodium chloride). Use
roller bottle in hybridization oven. Prepare cDNA probe following protocol (Amersham
Gene Images Alkphos Direct Labeling and Detection System). Add 15-20 µl of probes
and hybridize blot at 55°C overnight. Preheat the primary wash buffer to 55°C. Discard
hybridization buffer and add heated primary buffer (2 M Urea, 0.1% (w/v) SDS, 50 mM
Na phosphate pH 7.0, 150 mM NaCl, 1mM MgCl2, blocking reagent 2 g 0.2% (w/v)) and
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wash for 10 minutes at 55°C, with gentle agitation. Perform a further wash in primary
wash buffer at 55°C for another 10 minutes. Place the blots in a clean container and add
25 mL 1X secondary wash buffer (20x stock Tris base 121 g 1 M, NaCl 112 g 2 M, pH
10.0. Dilute to 1X with 2 mL of 1 M MgCl2) with gentle agitation for 5 minutes at room
temperature. Perform a further wash in fresh, secondary wash buffer at room temperature
for 5 minutes.
Drain the excess secondary wash buffer from the blots by using filter paper and place
them (sample side up) on a clean plastic wrap. Pipette detection reagent
(Chemiluminescent reagent CDP-Star) on to the blots (30–40 µl/cm2) and leave for 2–5
minutes. Drain excess detection reagent by touching the corner of the blot with tissue.
Wrap the blots in plastic wrap with blots DNA side up and place it in the film cassette.
Place a sheet of autoradiography film (Hyperfilm™ ECL) on top of the blots in the dark
room. Close the cassette and expose for 30 mins at room temperature and develop the
film. If required, expose a second film for an appropriate length of time.

2.2.16 DNA probe preparation for Northern blot analysis
The DNA probe is made by Amersham Gene Images Alkphos Direct Labeling and
Detection System with purified cDNA from RT-PCR. Add 100ng cDNA and add DNasefree water up to 10 µl. Place 10 µl of the diluted DNA sample in a microcentrifuge tube
and denature by heating at 100°C for 5 minutes. Immediately cool the DNA on ice for 5
minutes and spin briefly. Add 10 µl of reaction buffer, 2 µl labelling reagent, 10 µl of the
crosslinker working solution and mix thoroughly. Spin briefly and incubate the reaction
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for 30 minutes at 37°C. The probe can be used right way or kept on ice for up to 2 hours.
To preserve for a long time, probes can be stored in 50% (v/v) Glycerol at -20°C.

2.2.17 Genetic cross
C. elegans are grown up and maintained on NGM plates seeded with E. coli OP50.
Males from one strain can be obtained using him-14 RNAi or incubate worms at 37°C for
45 minutes.
Put 2-3 L4-stage hermaphrodite worms of one strain on a petri with 5-8 L4 males of
the second strain. Incubate at 24°C (ideal for germline expression) or 20°C (in the case of
adult expression) for 24 hours. Kill all the P0s (hermaphrodites as well as males). If you
can find many males in the F1 progenies, your crossing is successful. After 24 hours,
transfer 4 individual F1 hermaphrodites from crossing plate to single petri dish and let
them grow up to lay eggs. Pick a total of 16 individual F2 worms from petri dish and let
grow up to adulthood. Check the phenotype or genotype in F3 progenies usually by PCR
or florescence visualization. We always introduce FR1gfp replicon into the RNAideficient mutants, so GFP can be observed after heat induction if the mutants are
homozygous.

2.2.18 Integration
A significant advance in nematode transgenics was the discovery of microparticle
bombardment that can induce integrative transformation in C. elegans [105]. With this
technique, chromosomal breaks can be induced. The transgene arrays are then able to
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ligate to chromosomes during DNA repair. Outcross of integrated strain with wild type
several times is required at following step.

2.2.19 single molecule Fluorescent In-Situ Hybridization (smFISH)
Fixation:
smFISH was performed by using fluorophore-conjugated probes, Hybridization Buffer,
Wash Buffer A, B from BioSearch Technologies, which are specifically designed for
RNA FISH. Larvae were grown in a plate seeded with regular OP50 bacteria or OP50
with Orsay virus. All the worms are washed off by Nuclease-free water. Spin down
worms and incubate them in 1 ml fixation buffer (10% (vol./vol.) 37% Formaldehyde
solution, 10% (vol./vol.) 1 X Phosphate Buffered Saline (PBS)) at room temperature for
45 min. Then spin down and wash twice with 1 ml 1 X PBS. To permeabilize, add 1 mL
of 70% ethanol and store overnight at 4°C (Note: worms can be stored at 4 °C in 70%
ethanol for at most one week).
Hybridization:
Centrifuge and aspirate off 70% ethanol. Add 1 ml of Wash Buffer A, and incubate at
room temperature for 2-5 minutes. Aspirate Wash Buffer A and dispense 100 µl of the
Hybridization Buffer containing proper amount (1-5 µl) of probes into the tube. Incubate
samples in the dark at 37 °C for at least 4 hours. Then add 1 ml of Wash Buffer A to the
tube and incubate in the dark at 37 °C for 30 minutes. Aspirate Wash Buffer A and add 1
ml Wash Buffer A containing 5 ng/mL DAPI to counterstain the nuclei and incubate in
the dark at 37 °C for 30 minutes. Aspirate the supernatant and add 1 ml of Wash Buffer
B. Incubate at room temperature for 2-5 minutes. Add a small drop of VECTASHIELD
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Mounting Medium (VECTORLABS) onto the hybridized worms. Place the worms onto a
clean glass microscope slide and cover them with worm oil. The worms are ready to
proceed to imaging.

2.2.20 Sanger sequence preparation
The BigDye® Terminator v3.1 Cycle Sequencing Kit was applied to provide premixed reagents for Sanger sequencing reactions. Prepare 10 µl reaction mix (3.5 µl 2.5X
BigDye reaction buff, 0.5 µl BigDye Terminator, 1 µl 3.2µM primer, 1-4 µl DNA
Template, DNA nuclease free water to make the total volume as 10 µl) and perform
thermal cycling conditions (Table 1).
Table 1. Cycle of sequencing

Briefly centrifuge the reactions and add 30 µl 100% ethanol and 2.5 µl 125mM EDTA.
Mix thoroughly by vortexing it. Wait for 15 min and then centrifuge at 12000 rpm for 20
min at 4 ℃. Discard the supernatant and suspend sequencing products with 10 µl ABI
Hi-Di Formamide. The samples are ready for Sanger sequencing.
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2.2.21 EMS mutagenesis
Grow five 10 cm diameter Petri plates with worms. Wash all the worms with M9 and
transfer them in a sterile, 15 ml centrifuge tube. Centrifuge at 2000 rpm for 5 minutes.
Aspirate the liquid and use 2 ml of M9 to resuspend the worms. Dilute 20 µl EMS in a
tube containing 2 ml M9. Then add this EMS diluted solution to the 2 ml of worm
suspension to reach the final concentration of EMS at 47 mM. Place the tube horizontally
in the fume hood and let the worms incubate for 3.5 hours. Aspirate the supernatant and
discard it into a beaker containing 1N NaOH to inactivate the EMS. Add 5 ml M9 to the
worms and invert the tube several times to wash the worms. Centrifuge at 2000 rpm for 5
mins and aspirate the supernatant. Repeat the washing step at least 3 times. Suspend the
worm pellet with M9 transfer them onto NGM plates seeded with OP50 bacteria. Let the
mutagenized worms self-fertilize and screen the F2 generation progenies according to
phenotypes.

2.2.22 Library Construction
The preparation of library is performed by using TruSeq DNA PCR-Free Library
Preparation Kit from Illumina.

2.2.22.1 Genomic DNA shearing

Prepare 10 µg input genome DNA for each library. Use Diagenode bioruptor NGS for
genome DNA (gDNA) shearing (15 secs “ON”, 90 secs “OFF” 9 cycle).
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2.2.22.2 Cleanup

Quantify gDNA using electrophoresis and normalize gDNA with RSB to 55 µl.
Centrifuge and transfer 52.5 µl DNA to Covaris tubes. Then centrifuge and transfer 50 µl
supernatant to the CSP plate. Add 80 µl SPB, mix well and incubate at room temperature
for 5 minutes. Put the tube on a magnetic stand and wait until the liquid is clear. Discard
all supernatant and wash twice with 200 µl 80% EtOH. Remove EtOH carefully (Note:
avoiding touching beads) and then air-dry beads on the magnetic stand for 5 minutes.
Add 52.5 µl RSB to resuspend the beads. Remove the tube from the magnetic stand and
vortex. Incubate at room temperature for 2 minutes and place it on a magnetic stand
again. Wait until the liquid is clear. Transfer 50 µl supernatant to the IMP plate.

2.2.22.3 Repair ends and library size selection

Add 10 µl CTE and 40 µl ERP2 or ERP3 and mix by pipetting. Place on the thermal
cycler and run the ERP program by setting up 30°C for 30 minutes and Hold at 4°C.
Dilute SPB with PCR grade water to 160 µl per 100 µl of end-repaired sample
(Determine the volumes using Table 2). Vortex diluted SPB until well-dispersed.

Table 2. The amount of SPB and PCR grade water needed in library size selection.

Diluted SPB for a 350
bp insert Size

Formula

Example Amount per
12 samples

SPB

# of samples X
109.25ul

1311ul

PCR grade water

# of samples X
74.75ul

897ul
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Your
Calculation

Add 160 µl diluted SPB and mix up. Incubate at room temperature for 5 minutes. Put
the tube on a magnetic stand and wait until the liquid is clear. Suck up 250 µl supernatant
and transfer it to the CEP plate. Add 30 µl SPB and mix well. Incubate it at room
temperature for 5 minutes. Place the tube on a magnetic stand and wait until the liquid is
clear. Discard all supernatant and wash twice with 200 µl 80% EtOH. Remove all the
EtOH and air-dry on the magnetic stand for 5 minutes. Add 17.5 µl RSB after removing
the tube from the magnetic stand and mix by vortex. Incubate at room temperature for
another 2 minutes. Place on a magnetic stand and wait until the liquid is clear. At last,
transfer 15 µl supernatant to the ALP plate.

2.2.22.4 Adenylate 3’ Ends of DNA fragments

Add 2.5 µl RSB, 12.5 µl ATL or ATL2, and then vortex it. Use thermal cycler and run
the ATAIL70 program by choosing the preheat lid option and set it to 100°C. Reaction is
proceeded at 37°C for 30 minutes, 70°C for 5 minutes and 4°C for holding.
2.2.22.5 Ligate Adapters to DNA fragments

Add 2.5 µl RSB, 2.5 µl LIG2, 2.5 µl DNA adapters and mix thoroughly. Centrifuge at
280 × g and add 5 µl STL.

2.2.22.6 Clean Up Ligated Fragments

Add SPB 42.5 µl and incubate at room temperature for 5 minutes. Put the tube on a
magnetic stand and wait until the liquid is clear. Remove all the supernatant and wash 2
times with 200 µl 80% EtOH. Remove residual EtOH and air-dry the beads on the
magnetic stand for 5 minutes. Add 52.5 µl RSB and remove the tube from the magnetic
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stand. Resuspend the beads by vortex and Incubate at room temperature for 2 minutes.
Centrifuge at 280 × g for 1 minute and place the tube on a magnetic stand again. Wait
until the liquid is clear, then transfer 50 µl supernatant to the CAP plate. Repeat the steps
above by adding 50 µl SPB and using 22.5 µl of RSB in the later step. At last, transfer
20 µl supernatant to the TSP1 plate. (See Table 3 for all acronym definition)
Table 3. Acronym Definition
ALP

Adapter Ligation Plate

ATL

A-Tailing Mix

CAP

Clean Up ALP Plate

CEP

Clean Up End Repair Plate

CSP

Clean Up Sheared DNA Plate

CTA

A-Tailing Control

CTE

End Repair Control

CTL

Ligation Control

DAP

DNA Adapter Plate

DCT

Diluted Cluster Template Plate

DNA

Customer Sample DNA Plate

ERP

End Repair Mix

IMP

Insert Modification Plate

LIG

Ligation Mix

PDP

Pooled Dilution Plate

RSB

Resuspension Buffer

SPB

Sample Purification Beads

STL

Stop Ligation Buffer

TSP1

Target Sample Plate 1
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2.2.23 DNA library building and quality check
DNA libraries were constructed by using PCR-free Truseq DNA kit (Illumina).
Indexed sequences of each candidate mutant are shown below (table 4). Gel analysis and
Bioanalyzer are utilized to check the quality and quantity of libraries by observing the
distribution of DNA fragments.

Table 4. Information of Indexed adaptor for each candidate library
Candidate mutants

Indexed adapter sequence

11/B05

CGATGT

11/N2

TGACCA

11/1031A

ACAGTG

11/1027E

GCCAAT

11/1029E

CAGATC

11/D03

CTTGTA
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CHAPTER 3: DEVELOPMENT OF A REPORTER WORM
STRAIN FOR BIASED GENETIC SCREEN
Introduction
RNA interference is an essential immune response to RNA virus across species. In the
recent study, RNAi as an antiviral immune mechanism was also found in mammals [7-9].
In the invertebrate Caenorhabditis elegans, the antiviral RNAi process is initiated by a
single dicer, which is in the RNase III family that specifically binds and cleaves dsRNA.
The efficient recognition process requires RDE-4 (RNA defective 4), a dsRNA binding
protein and DRH-1, which encodes helicase and C-terminal domains homologous to the
mammalian RIG-I-like helicase family of cytosolic immune receptors. After dsRNAs are
processed into siRNAs, the siRNAs are then loaded into RDE-1 (RNA defective 1), an
Argonaut protein which is an important component in RISC and guides RISC to target
mRNA by complementary mechanism for subsequent mRNA destruction. Antiviral
RNAi can also be amplified in nematodes. RdRP and RSD-2 contribute to the biogenesis
and functionality of secondary siRNA. However, the underlying molecular mechanisms
are not well understood. In the current study, I developed a biased genetic screen strategy
to identify novel genes involved in RDVI, which may help us gain insight into the
molecular mechanisms. Four critical genes involved in C. elegans RDVI (drh-1, rde-1,
rde-4, rrf-1), an artificial virus FR1gfp and a transgene reporter (Pmyo2::mCherry) were
delivered together into rde-1; rde-4 double mutant through gonad microinjection. The
high viral susceptibility was reduced by ectopic expression of the rde-1 and rde-4. I then
examined FR1gfp expression by using feeding RNAi-based assays and confirmed its
existence in transgenic array. Moreover, ectopic expression of drh-1 and rsd-2 rescued
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RDVI response, suggesting the existence of drh-1 and rsd-2 transgenes in the transgenic
array. I also studied antiviral response of our transgene array in drh-3 and rrf-1 (RNAdependent RNA polymerase) background, in which the replication of viruses was readily
detected, suggesting that overexpression of drh-1, rde-1, rde-4 and rsd-2 does not
compensate the loss of antiviral RNAi in rrf-1 or drh-3 mutants. Thus, when wild-type
N2 worms that contain the developed transgene array are used for large scale genetic
screen, any loss of function alleles associated with drh-1, rde-1, rde-4 and rsd-2 will be
automatically rejected, which will significantly speed up our gene discovery process.
There are two types of genetic screen strategies in the worm system: forward genetics
and reverse genetics. Forward genetic screen is the most common genetic screen for
identifying recessive mutations. Typically, P0 hermaphrodites are treated with mutagen at
late L4 or early adult stages. F1 progenies, heterozygotes are allowed for self-fertilization
and F2 animals are screened based on the phenotype expected. The most widely used
mutagen for C. elegans is EMS as well as trimethylpsoralen with ultraviolet light
(UV/TMP) [106]. Reverse genetic screen begins with the generation of worm mutants by
targeting and downregulating each of the worms’ genes. Then, the candidate gene can be
identified by screening for phenotypes that are generated as a result of gene silencing. In
1998, ingesting of dsRNA from bacterial food was found to trigger potent silencing of
homologous gene [36, 37]. This finding makes it possible for rapid gene discovery
through reverse genetic screen in C. elegans. However, both strategies for genetic screen
have their drawbacks. Forward genetic screen requires a large workload and amount of
lab resources. This is mainly because although it is relatively easy to isolate genetic
mutants with desired phenotype, characterization of the genetic alleles involved through

46

conventional map-based cloning strategy is labor intensive and cost ineffective process.
In a reverse genetic screen, although it is easy to find out which gene is involved once the
desired phenotype is identified, sometimes it is difficult, if not impossible, to achieve
complete silencing of the target gene through feeding RNAi. Previously it has been
shown that feeding RNAi does not work well when the target gene itself is a key
component of RNAi. Therefore, I have chosen to use forward genetic screen strategy for
gene discovery in our study. The efficiency of the screen is dramatically improved by (1)
using virus as reporter so that the genes specifically contributing to antiviral defense will
be targeted; (2) introducing extra copies of four known antiviral RNAi genes can
significantly reduce our workload since these four genes will not be targeted during our
screen.
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Results
3.1 FR1gfp: a viral reporter for loss of antiviral RNAi in C. elegans
In our study, I utilized a viral replicon transgene called FR1gfp as the reporter for loss
of antiviral RNAi in C. elegans.
FR1gfp is engineered using flock house virus RNA1 as backbone [107]. FHV is a

Fig 12. Schematic representation of FR1gfp transgene and genome structure of Flock House
Virus. (A) FR1gfp transgene is generated based on Flock House Virus RNA1 by replacing B2
with GFP. A heat-shock promoter (HSP) is at 5‘ end and a self-splicing ribozyme sequence is
at the 3’ end. After heat induction, the subgenomic RNAs containing GFP sequence, are
produced. (B) Expression of wild type FHV RNA1 (FR1) produces FHV RdRP and
expression of FHV RNA3 (FR3) produces RNAi suppressor B2 protein of FHV. (C)
Expression of wild type FHV RNA2 (FR2) produces the precursor protein of FHV.

positive-strand RNA virus in the family Nodaviridae. FHV contains two genomic
segments called RNA1 and RNA2. RNA1 encodes the viral RdRP (Fig 12B) whereas
RNA2 encodes precursor protein of the coating protein (Pre-CP) (Fig 12C). RNA1 can
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perform self-replication in the absence of RNA2. The 3' end of RNA1 encodes a
subgenomic RNA called RNA3, which is transcribed during RNA1 replication (Fig 12B).
RNA3 is required to initiate FHV infection under normal condition since it encodes the
RNAi suppressor protein B2 (Fig 12B) [108].
It is important to note that FR1gfp is defective in RNAi suppression because B2, the
RNAi suppressor, is replaced by GFP. Therefore, B2 function is totally disrupted, but
replication and expression of viral RNA1 is not influenced when antiviral RNAi is
defective. In addition, a self-cleaving ribozyme sequence is fused to the 3’ end of FR1gfp
so that the poly-A tail, which can inhibit viral replication, will be removed by the
ribozyme (Fig 12A).
Under normal condition, FR1gfp cannot replicate due to the loss of B2 function.
However, if antiviral RNAi is suppressed as a result of B2 co-expression or genetic
disruption of RNAi activity, FR1gfp and gfp expression will be restored. In this way,
replication of FR1gfp can be easily visualized by observing GFP in the worm body.
Therefore, FR1gfp can be used as viral reporter to look for genes required for antiviral
defense.

3.2 Development of the plasmid constructs that express wild-type rde-1 and rde-4 in C.
elegans
I developed two transgenes, Psur-5::rde-1::UTR and Psur-5::rde-4::UTR, that will
express wild-type rde-1 and rde-4 in C. elegans. The Psur-5 promoter can initiate the
transcription in almost all the cells of C. elegans, including the vulva precursor cells
(VPCs). 3’ UTR from unc-54 contains post-transcriptional regulatory regions that plays
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important role in transcription termination and serves as target for microRNAs
(miRNAs) to bind, thus influencing the expression of genes. Wild-type rde-1 and rde-4
cDNA are synthesized from corresponding mRNAs extracted from wild type N2 worms.

3.3 Generation of a reporter transgene array for biased genetic screen
The reporter transgene array to be generated is expected to harbor six transgenes.
Four constructs (Psur-5::rde-1::UTR, Psur-5::rde-4::UTR, Psur-5::drh-1::UTR, Psur-

Fig 13. The figure shows the structure of transgene array including Psur-5::rde1::UTR, Psur5::rde4::UTR, Psur-5::drh-1::UTR, Psur-5::rsd-2::UTR, HIP::RdRP::GFP,
Pmyo2::mCherry::UTR. Psur-5, the promoter for the endogenous gene sur-5; rde-1, the
coding sequence of wild-type rde-1; rde-4, the coding sequence of wild-type rde-4; drh-1, the
coding sequence of wild-type drh-1; rsd-2, the coding sequence of wild-type rsd-2; UTR, the
3’-end untranslated region of unc-54.

5::rsd-2::UTR) will be delivered to express four known genes involved in antiviral
RNAi. These four constructs will direct the expression of rde-1, rde-4, drh-1 and rsd-2
respectively. The other two transgenes are Pmyo2::mCherry reporter and HIP::FR1gfp
transgene (Fig 13). The Pmyo-2::mCherry-derived transgene is expected to direct
50

mCherry expression in the head of transgenic worms and, thus, will serve as selection
marker for the transgene array to be created. The HIP:FR1gfp-derived transgene will
serve as reporter of loss of antiviral RNAi in this study.

3.3.1 Generation of a reporter extrachromosomal array in rde-1; rde-4 double mutants.

In C. elegans, gonad injection of target gene construct often leads to the formation of
extrachromosomal arrays that are made of multiple copies of the target constructs. This
unique feature has made it possible to co-deliver many genes into C. elegans genome in a

Fig 14. RDVI was restored in rde-1;rde-4 double mutants containing the extrachromosomal
array generated through gonad injection. Co-injection of 6 plasmid constructs shown in Figure
13 restored antiviral RNAi in rde-1;rde-4 double mutants that contain an FR1gfp transgene.
There are four worms in the picture, two worms on the left contain extrachromosomal array
(red fluorescence in the head) and two on the right without it (no red fluorescence in the
head). Visualization of GFP was performed 24 hours after heat induction. The image was
produced by merging images recorded under red and green fluorescence using the same
exposure.

single transformation process. Based on this observation, I decided to develop a unique
reporter worm strain that will allow for rapid identification of novel RDVI genes in C.
elegans. Such a unique reporter worm will contain a transgene array that harbors a viral
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reporter transgene and four more transgenes corresponding to drh-1, rde-1, rde-4 and rsd2. Genetic screen utilizing a reporter worm strain that contains extra copies of drh-1, rde1, rde-4 and rsd-2 will not pick up any alleles associated with these four genes. As a
result, the screen efficiency will be significantly improved. To develop such a reporter
worm strain, I mixed 6 plasmid constructs, corresponding to Pmyo-2::mCherry::UTR,
HIP::FR1gfp, Psur-5::drh-1::UTR, Psur-5::rde-1::UTR, Psur-5::rde-4::UTR, and Psur5::rsd-2::UTR respectively (Figure 13), and injected them into rde-1;rde-4 double
mutants that already contain an HIP::FR1gfp-derived transgene. My injection produced 5
independent strains that carry extrachromosomal arrays visualized as red fluorescence in
worm head. To find out whether functional Psur-5::rde1::UTR, Psur-5::rde-4::UTR
transgenes were successfully incorporated into the extrachromosomal arrays, I checked
FR1gfp replication, manifested by GFP expression, in the worms that contain the
extrachromosomal arrays. In all the 5 transgenic strains, as shown in Figure 14, bright
green fluorescence was observed in progeny worms that are free of the extrachromosomal
arrays, whereas no green fluorescence was detected in progenies that carry the
extrachromosomal arrays (compare worms showing no red fluorescence in head and
worms with red fluorescence in head).
To reconfirm this result, I generated a chromosomal integrant, named 48, for one of
the 5 transgenic strains and checked the accumulation of FR1gfp-derived viral RNAs
using northern blots. As shown in Figure 15A, FR1gfp derived genomic (RNA1) and
subgenomic RNAs (RNA3) can be readily detected in the positive control rde-1; rde-4

52

double mutants but not in 48 worms. These findings together suggest that the
chromosomal integrant 48 contains functional rde-1 and rde-4 transgenes.

Fig 15. RDVI is restored in the chromosome integrant 48. (A) Accumulation of FR1gfp
transcripts in single and double mutants corresponding to rde-1 and rde-4 as indicated. *
indicates worms that carry the 48 transgene array. The FR1gfp transcripts were detected by
northern blotting, for which the probe was prepared using GFP coding sequence; RNA1,
FR1gfp genomic RNA; RNA3, FR1gfp subgenomic RNA. Methylene blue stained ribosomal
RNA (rRNA) serves as equal loading control. (B) Northern blot detection of Orsay virus
RNA1, OvRNA1, in single and double mutants corresponding to rde-1 and rde-4 as indicated.
* indicates worms that carrying the 48 transgene array. Orsay virus RNA1 cDNA was used to
prepare probe for the detection of Orsay virus RNA1 through northern blotting.

Orsay virus is a novel RNA virus distantly related to nodaviruses. This virus was
isolated from the C. elegans strain JU1580 based on the observation that JU1580 has
abnormal morphological phenotypes in intestinal tissue [110]. When Fluorescent In-situ
Hybridization (FISH) was used to detect Orsay virus RNA using sequence-specific
probes, it was clear that Orsay virus only replicates in the intestinal cells [110]. In
previous studies, Orsay virus was shown to accumulate to a much higher level in RNAi
mutants, compared to that in wild type N2 worms, suggesting that Orsay virus invokes
and is under the control of RDVI response in C. elegans. These findings together
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suggested that Orsay virus is a good model virus to study essential genes required for
antiviral immunity in C. elegans [110].
The genome structure of Orsay virus is very similar to that of FHV. Both viruses
contain two genomic segments with RNA1 encoding RNA-dependent RNA polymerase
and RNA2 encoding the precursor protein of viral coating protein (Fig 16). However,
currently there is no experimental evidence to show that Orsay viruses generate
subgenomic transcripts from the RNA1 like FHV RNA1 does. Thus, Orsay virus RNA1
may not encode suppressor proteins. For detection of Orsay virus infection, I prepared
cDNA probes that are complementary to the segment of Orsay virus RNA1.

Figure 16. Schematic of genomic organization of Orsay virus. The RNA1 segment (2,680
nucleotides) encoded a predicted ORF (open reading frame) of Orsay virus RdRP, and the
RNA2 segment was predicted to encode a capsid protein at its 5’ end. A second ORF
encoding Delta protein is discovered at the 3‘end. (From Marie-Anne Félix and David W
[109])

As shown in our northern blot analysis, the accumulation of Orsay virus RNA1 in the
rde-1;rde-4 double mutants containing the transgene array is much lower than that in
single and double mutants that do not contain the transgene array (Fig 15B). The
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Northern blot results of Orsay virus replication strongly confirmed that in 48 worms both
rde-1 and rde-4 transgenes are functional.

3.3.2 Characterization of the FR1gfp transgene in the reporter transgene array

To develop a reporter worm strain for the identification of novel RDVI genes, I
introduced the reporter transgene array generated in 48 worm which is marked by the
Pmyo-2::mCherry transgene into wild type N2 worms and obtained a new strain named
48/N2. 48/N2 worms are free of any developmental defects and, thus, would serve us
well as a reporter worm strain for the identification of RDVI genes if the viral reporter
FR1gfp in the transgene array is functional. To find out whether the viral reporter FR1gfp

Fig 17. The Viral reporter FR1gfp is functional in 48/N2. (A) Visualization of green
fluorescence in 48/N2 worms subjected to feeding RNAi targeting rde-1 and rde-4.
Photographs were taken 24 hours after induction of the replicon replication. See content in
2.1.2 for experimental details. There are four worms sticking together in the left picture, three
worms in the middle picture and five worms in the right picture (B) Accumulation of Orsay
virus RNA1 in rde-1 and rde-4 mutants and wild type N2 worms that carry the 48 transgene
array. * indicates worms that were fed with E. coli food expressing rde-1 dsRNA. **
indicates worms that were fed with E. coli food expressing rde-4 dsRNA.
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in 48/N2 is indeed functional, I checked GFP expression when the expression of rde-1
and rde-4 is downregulated by feeding the 48/N2 worms with food expressing rde-1 or
rde-4 dsRNA. The feeding RNAi would silence both endogenous genes and transgenes
corresponding to rde-1 or rde-4 thereby to rescue the replication of FR1gfp, leading to
the production GFP fluorescence. Indeed, as shown in Fig 17A, in response to rde-1 or
rde-4 dsRNA feeding, FR1gfp is able to replicate and produce green florescence after
heat induction.
To find out whether the expression of rde-1 and rde-4 can be suppressed to enable the
infection by natural viral pathogens, such as Orsay virus, I challenged the 48/N2 worms
with Orsay virus when rde-1 or rde-4 were silenced by feeding RNAi. As shown in
Figure 17B, the accumulation of Orsay virus was significantly increased when 48/N2
worms were fed on E. coli food expressing either rde-1 or rde-4 dsRNA. These results
thus confirmed that RDVI in 48/N2 worms can be subdued by dsRNA feeding to allow
for the infection by natural viral pathogens.
These results together suggest that both FR1gfp reporter transgene and the transgenes
corresponding to rde-1 and rde-4 are functional in 48/N2 worms.
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3.3.3 Characterization of the drh-1 and rsd-2 transgene in the reporter transgene array

To find out whether the drh-1 and rsd-2 transgenes in the 48/N2 worms are functional
for antiviral defense, I delivered the corresponding transgene array into drh-1 and rsd-2
mutants by genetic cross and tested both FR1gfp and Orsay virus replication in the new
strains 48/drh-1 and 48/rsd-2. I reasoned that if the drh-1 and rsd-2 transgenes in the
transgene array are functional, they should be able to rescue the function of endogenous

Fig 18. Both drh-1 and rsd-2 transgenes have been successfully integrated into the transgene
array 48. (A) Northern blot detection of FR1gfp replication in transgenic worm strains, as
indicated, that contain the 48 transgene array after heat induction. See content of 2.1.2 for
experimental details. (B) Accumulation of Orsay virus RNA1 in drh-1 and rsd-2 mutants and
wild type N2 worms that carry the 48 transgene array. In both figure 18A and B, * indicates
worms that were fed with E. coli food expressing drh-1 dsRNA. ** indicates worms that were
fed with E. coli food expressing rsd-2 dsRNA. See content of 2.1.2 for experimental details.

drh-1 and rsd-2 and, as a result, the replication of both viruses will be suppressed in
48/drh-1 and 48/rsd-2 worms. Indeed, as shown in Figure 18A and Figure 18B, the
replication of FR1gfp and Orsay viruses was suppressed in drh-1 and rsd-2 mutants
containing the transgene array. Apparently, the restoration of RDVI in 48/drh-1 and
48/rsd-2 worms can only be ascribed to the function of drh-1 and rsd-2 transgenes
respectively as the replication of FR1gfp and Orsay virus was restored when the
expression of drh-1 and rsd-2 transgenes were silenced by dsRNA feeding.
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3.4 Sensitivity test of the reporter worm strain
Recent studies have shown that DRH-3 is required for germline development and
RNAi by participating in the biogenesis of endo-22G RNAs [46, 111, 112]. Consistent
with these observations, we have recently demonstrated that drh-3 mutant is susceptible
to the infection by both Orsay virus and FHV [3], suggesting a role of drh-3 in RDVI.
The RNA-dependent RNA polymerase RRF-1 is required for the production of
secondary siRNAs and has been shown to play a role in RDVI [30, 38, 40, 43, 91].
However, unlike that in drh-1 or rde-1 mutants where the viral replication can be fully
restored, viral replication in rrf-1 mutants can only be partly restored [7].
To rule out the possibility that overexpression of four RNAi worm genes
compensates the function loss for some other antiviral RNAi genes, making my reporter
worm strain less sensitive in picking up some loss of function alleles, I decided to check
whether virus replication is suppressed in rrf-1 and drh-3 mutants containing the reporter

Fig 19. Virus replication in 48/drh-3 and 48/OK589 in dsRNA feeding-based assays. (A)
Northern analysis of Orsay virus accumulation in 48/drh-3. N2, drh-3 and 48/N2 were set as
control. (B) Northern analysis of Orsay virus accumulation in 48/OK589 and 48/drh-3. (C)
Northern analysis of FR1gfp accumulation in 48/OK589. 48/N2 and 48/drh-3 were used as
negative and positive control, respectively. OK589 is one allele of rrf-1 mutant.
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transgene array. To this end, I introduced the reporter transgene array into drh-3 and rrf-1
worms and checked viral replication in the resulting worm strains. As shown in Fig 19A
and B, both 48/drh-3 and 48/rrf-1 are highly susceptible to Orsay virus infection.
Consistently, I observed green fluorescence in both 48/drh-3 and 48/rrf-1 worms
although a higher percentage of green fluorescent worms was observed in 48/drh-3 strain
compared to that in 48/rrf-1 strain. Our Northern blot analysis confirmed that the FR1gfp
RNAs indeed accumulated to a higher level in 48/drh-3 worms than that in 48/rrf-1
worms and both worms strain showed higher viral replication than the 48/N2 worms (Fig
19C). These results together suggest that the 48/N2 worms will be sensitive enough to
pick any genetic alleles that compromise worm RDVI.

Discussion
To develop a reporter worm strain that will allow for the identification of novel
RDVI genes without hitting previous identified ones, I generated a transgene array that is
expected to contain an FR1gfp viral reporter and transgenes corresponding to 4 known
RDVI genes, drh-1, rde-1, rde-4 and rsd-2. The transgene array was generated in rde-1
and rde-4 double mutants through gonad microinjection. The restoration of RDVI in the
double mutants suggests that both rde-1 and rde-4 transgenes in the transgene array are
functional (Figure 14, 15). To find out whether the viral reporter transgene FR1gfp was
successfully delivered into this transgene array, I checked GFP expression in worms
containing this transgene array. I found that when the expression of rde-1 or rde-4 was
suppressed by feeding RNAi, green fluorescence can be observed in worms carrying this
transgene array, confirming the viral reporter FR1gfp was indeed successfully delivered
(Figure 17). I further showed that this transgene array can rescue the function of drh-1
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and rsd-2 in respective loss of function mutants (Figure 18A, B), suggesting that all these
RDVI transgenes in the transgene array are functional. Importantly, RDVI remains
defective in drh-3 and rrf-1 mutants containing the transgene array (Figure 19),
suggesting that overexpression of four known RDVI genes does not compensate for the
function loss of other RDVI genes. The results indicate that wild-type N2 worms carrying
this transgene array will serve us well as a reporter for the identification of novel RDVI
genes through genetic screen.
In this study, I chose FR1gfp, which is modified from FHV RNA1, as the reporter for

Fig 20. Visualization of GFP in two worm strains with FR1gfp transgene. The worm at top is
wild type and the worm at bottom is rde-1 mutant. GFP level is observed 24 hours after heat
induction.

large-scale genetic screen [107]. The GFP coding sequence was used to replace part of
RNA3 sequence so that B2 function is destroyed but the function of RdRP is not affected.
Therefore, FR1gfp is able to replicate in the strains deficient in antiviral defense, but not
in the strain where antiviral RNAi machinery is still functional. The replication of
FR1gfp can be easily visualized by observing GFP in the body muscle (Fig 20), making it
practical to screen genes specific for antiviral defense.
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Based on the previous study, I believe that Orsay virus could serve as an alternative
viral reporter for loss of antiviral RNAi. In theory, it should be possible to create Orsay
virus replicon harboring GFP sequence for visualization of viral replication. For instance,
GFP sequence could be fused to Orsay virus RNA1 to generate fluorescent version of
Orsay RNA1 transgene. After introducing the transgene into RNAi defective worm
strain, Orsay virus replication can be visualized. This transgene is also ideal as a viral
reporter for large-scale genetic screen for host antiviral genes. However, it seems there
are some limitations on the size of insertions that can be tolerated in Orsay virus genome
[113]. Currently it remains to be a challenge to generate an Orsay viral based reporter.
Using FR1gfp as a reporter for genetic screens has three major advantages. First, this
reporter allows for identification of genes specifically involved in antiviral defense.
Second, GFP as a visual mark of viral accumulation is easy to detect. Third, FHV
replicates in insects, plants, yeast and animals. Thus, FR1gfp can be used as reporter for
loss of antiviral RNAi in genetic screens in other systems. Since many key antiviral
RNAi genes are conserved across kingdoms, study on the conserved genes may have
direct input to antiviral RNAi study in other systems. There are disadvantages associated
with the FHV reporter as well. For example, the initiation of FR1gfp through the
transgene strategy often results in very high level viral replication. As such, the function
of host antiviral RNAi machinery may become saturated, leading to false positive during
genetic screens. This is why repetitive reconfirmation is always required to get rid of the
false-positives. Sometimes, the sudden increase of FR1gfp transcripts can be lethal. This
is mainly because the basic cellular functions are compromised as a result of irregular
expression of essential host genes.
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Although it is possible to generate a large transgene array in C. elegans using the
gonad microinjection technique, the expression of different transgenes in the transgene
array can vary dramatically. This is mainly because different transgenes may have
different copy numbers in the transgene array. Sometimes, some transgenes may simply
become silenced due to the triggering of gene silencing [114]. It was also observed that
some transgenes have the so-called mosaic expression pattern: they are expressed
normally in some tissues but become silenced in some other tissues. As a result, the
transgene may be expressed in some of the progeny [115]. Therefore, it is important to
pick up as many transgenic strains as possible for the selection of an ideal strain. It is
important to note that for some worm genes it might be difficult to generate a functional
transgene, especially those that are actively expressed in germline. Previously it has been
shown that transgenes in germline cell are strongly silenced [116].
In spite of some potential problems or drawbacks in developing large transgene
arrays, the reporter worm strain I have created seems working very well in this
preliminary study. In theory, it is possible to include more known genes in our transgene
array. I believe that the strategy can be adopted to dissect many other biological pathways
in the worm systems. It is important to note that I did not introduce the dcr-1 gene into
our transgene array. DCR-1 is essential to antiviral RNAi. However, it is also required for
synthesis of small RNAs, such as miRNAs, that are essential for development. Therefore,
irregular expression of dcr-1 may result in lethal embryos that will not hatch, making it
impossible to isolate transgenic worms containing the dcr-1 transgene. It is also worth
mentioning that I failed to develop a functional construct containing drh-3 gene. Both
HIP and Psur-5 promoter cannot drive the expression of a functional drh-3 transgene. I
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reasoned that this may be because drh-3 is an essential gene that is actively expressed in
germline tissue. Initiation of drh-3 transcription requires a specific promoter that is
currently unavailable. These are reasons that I didn’t include dcr-1 and drh-3 in 48
transgene array.

63

CHAPTER 4: MUTAGENESIS AND IDENTIFICATION OF
CANDIDATE GENES
Introduction
Genetic mutation is always the main force that drives creatures to evolve. In C. elegans,
spontaneous point mutations arise at the rate of 2 × 10−8 per gene per generation [117].
Mutation is also an important tool for gene function study. In the laboratory mutagenesis
techniques are widely used to produce various mutations in genes participating in the
biological pathway of interest.
Typically, there are three types of genome-wide mutagenesis: chemical, physical, and
transposon insertional mutagenesis. Chemical mutagenesis offers the most convenient
and easiest way to induce mutation. The most commonly used chemical mutagens in C.
elegans are EMS and UV/TMP. EMS is an alkylating agent which adds an ethyl group to
guanine and forms O6-ethylguanine [118]. The modified guanine can pair with thymine
instead of cytosine during DNA replication [119]. Therefore, the original G/C base pair
becomes A/T base pair. Most of the time, this transition mutation leads to the generation
of stop codons [120]. Consequently, the EMS-mediated mutations are normally loss-of
function or null allele.
TMP is a light-sensitive crosslinker of DNA, whose mutagenicity is activated by UV
light [121]. Reportedly, UV/TMP generates small deletions with the size of approximate
by one to three kilobases. In addition, its mutation rate depends on total UV exposure
[106].
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Physical mutagens include various types of radiations. For example, X rays, gamma
rays, UV light, etc. High-energy radiation can lead to large chromosomal deletions or
chromosomal rearrangement at relatively high rate [122].
Transposable element (TE or transposon) mutagenesis is achieved by transposon
insertion via a transposase enzyme. Transposons are DNA sequences that can move from
one location to another in the chromosome. Such a transposition process can result in
various alterations, including insertion, excisions, translocation and duplication [123].
In C. elegans, there are six families of endogenous transposons, Tc1-Tc5 and Tc7 [124129]. These transposons can be activated in Mutator background. For example, Tc1, the
most enriched transposon, can be effectively activated in mut-6 (a Mutator gene) mutant
[130]. Sometimes, an exogenous transposon Mos1-based method is preferred. Mos1,
which originates from Drosophila, is more likely to be inserted in introns presumably
because the areas tend to be T/A rich [131].

My biased genetic screen is based on forward genetic screen that uses EMS as
mutagen. I choose to use EMS as mutagen for three reasons: First, EMS mutagenesis is
very easy to administer. Second, EMS has the best efficiency of mutagenesis, compared
to physical method, transposon insertional methods and even the most popular UV/TMP
method. In other words, fewer animals are needed to be scored to identify a phenotype of
interest while using EMS mutagenesis in comparison with other methods [132]. Third,
transposon-mediated and radiation-based methods produce more complicated mutations
such as small indels (insertions and deletions) or chromosomal rearrangement [122, 133].
These events greatly increase the difficulty for gene identification.
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After mutagenizing my reporter worms with EMS, altogether 25 candidate alleles were
identified and were assigned to 13 candidate genes through genetic complementation
tests. Two of the alleles, 1025A and B09, turned out to have derived from rrf-1 and
1031B was confirmed to be a loss of function allele of rde-3. All of them were identified
through genetic complementation tests and validated by Sanger sequencing and function
rescue test. When I conducted tests that aim to determine whether these genes are
involved in both classical RNAi and antiviral RNAi, it was surprising to see three of the
asd (antiviral silencing deficient) genes are required for both classical RNAi and antiviral
RNAi. Other genes are very likely only required for antiviral RNAi or an RNAiindependent antiviral mechanism in C. elegans. More strikingly, some of these antiviraldedicated genes are critical for FHV antiviral response but do not confer resistance to
Orsay virus. After introducing Orsay RdRP as transgene into these mutants, I used
smFISH technique to detect the location of Orsay virus replication. Different patterns of
Orsay virus replication were detected for transgene-delivered Orsay virus, compared to
that during natural Orsay virus infection. Thus, these genes may function in a tissuespecific manner in antiviral response.
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Results
4.1 EMS mutagenesis
My biased genetic screen is based on forward genetics. To identify antiviral-deficient
strains, the reporter strain 48/N2 P0 hermaphrodites were mutagenized by EMS at the late
L4 or early adult stages. F1 progeny, heterozygous for many induced mutations, were
then allowed to self-fertilize. I triggered FR1gfp replication by heat inducing F2

Fig 21. Schematic of strategy for genetic screen triggered by EMS mutagenesis. After treating
with EMS mutagen, F1 heterozygotes contain mutations. In the F2 progenies, homozygotes
with expected mutant phenotype were selected.

progenies at 33C for 3 hours (Fig 21). The candidate strains that produced green
fluorescence were further confirmed by heat inducing the F3 progenies. The biased
genetic screen was conducted twice and altogether 25 loss of antiviral RNAi alleles were
isolated.
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4.2 Characterization of the candidate mutants through genetic complementation

Table 5. Thirteen candidate genes assigned by genetic complementation and their
physiological characteristics.
Candidate genes

Allele

Strength of
green
fluorescence

Temperature
sensitivity

Developmental
defects

Asd-1

D02

++++

+

Reduced brood size

1027e

+++

+

Reduced brood size

1026 (D03)

+++

+

Reduced brood size

1103a

++++

+

Reduced brood size

1026b(B01)

++++

-

-

1028g

++++

-

-

1029e

++++

-

-

1029c

++++

-

-

1031e

++++

-

-

1102b

+++

-

-

1025b

+++

-

-

1028f

++++

-

-

1029b

++++

1026a

++++

-

Reduced brood size

1031a

++++

-

Reduced brood size

1031f

++++

-

Reduced brood size

Asd-6 (rde-3)

1031b

++++

-

-

Asd-7

1028j

++++

-

-

Asd-8

1030d

+++

-

-

Asd-9

1026d(B05)

+++

-

-

Asd-10

1105a

+++

-

Reduced brood size

Asd-11

1030c

+++

-

High frequency of
males

rrf-1

1025a

+++

-

-

B09

+++

-

-

1026c (B03)

+++

-

-

Asd-2

Asd-3

Asd-4

Asd-5

Asd-12

-
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In genetics, complementation occurs when two genetic alleles derived from different
genes together produce wild type phenotype. Non-complementation happens when the
two genetic alleles are derived from the same gene. To find whether any of the isolated
alleles are derived from the same gene all the candidate mutants were crossed to each
other. In this complementation test, the phenotype is GFP expression in worm body 24
hours after heat induction. In addition, I also crossed these candidate mutants with
genetic mutants containing alleles corresponding to rrf-1, rde-2, rde-3, rde-10, rde-11,
rde-12, and drh-3, hoping to identify alleles derived from these known RNAi related
genes [40, 97, 134, 135].
25 candidate alleles were eventually assigned to 12 candidate genes through genetic
complementation. I analyzed their physiological characteristics by comparing GFP
expression level 24 hours after heat induction at 37C, testing temperature sensitivity by
allowing them to grow at 25C and checking brood size and male frequency (Table 5).
These tests suggest that only asd-1 alleles are sensitive to temperature. They become
sterile while growing at 25C. Moreover, asd-1, asd-5, asd-6 and asd-10 candidates have
about 5-fold reduction of brood size compared to wild type, implying these genes may be
essential for worm development. In addition, asd-11 allele has high frequency of males,
indicating this gene is probably associated with X-chromosome segregation.
My genetic complementation tests suggested one candidate allele is derived from rde-3
and two from rrf-1. Both rde-3 and rrf-1 are known RNAi genes with important function
in antiviral defense. Thus, the isolation of rde-3 and rrf-1 derived alleles suggests a good
coverage of the biased genetic screen.
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4.3 Function characterization of the identified candidate genes
Next, I want to further characterize candidate genes by determining whether they

Fig 22. (A) Strategy to deliver a transgene array termed as 11, which contains myo3mCherry
reporter and a FR1gfp reporter through genetic cross and (B) the schematic structure of
myo3mCherry transgene which has Pmyo-3 promoter at 5 prime and untranslated region at 3
prime (UTR). Pmyo3 is the promoter that can drive the expression of mCherry in body
muscles.

contribute to both classical and antiviral RNAi. With a replicating virus as the trigger and
target of RNAi, my genetic screen was expected to pick up genes with specific function
in antiviral RNAi. I tested their function in RNAi triggered by dsRNA ingestion. I did not
use the original mutants for this test, considering that some of the random mutations in
the original mutants may have adverse effect on feeding RNAi. Thus, my test began with
the introduction, through outcross, of the representative allele for each of the 12 asd
genes into a transgenic worm strain termed 11 (Fig 22A). 11 worms contain two
physically linked transgenes, a heat inducible FR1gfp transgene and a mCherry transgene
(Fig. 22B).
The FR1gfp transgene produces green fluorescence upon Heat induction when antiviral
RNAi is defective, whereas the mCherry transgene directs constitutive expression of
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Table 6. Sensitivity of the identified mutants to feeding RNAi targeting skn-1 and unc-22.
Candidate gene

Associated
Alleles

Sensitivity to skin-1
dsRNA feeding

Sensitivity to unc-22
dsRNA feeding

Asd-1

1026F

-

-

1027E

-

-

1103A

-

-

1026G

-

-

1026B

+

+

1028G

+

+

1029E

+

+

1029C

+

+

1031E

+

+

1102B

+

+

1025B

+

+

1028F

+

+

1029B

+

+

1026A

-

-

1031A

-

-

1031F

-

-

Asd-6 (rde-3)

1031B

-

-

Asd-7

1028J

+

+

Asd-8

1030D

+

+

Asd-9

1026D

+

+

Asd-10

1105A

+

+

Asd-11

1030C

+

+

rrf-1

1025A

-

-

B09

-

-

1026C

+

+

Asd-2

Asd-3

Asd-4

Asd-5

Asd-12

mCherry in body wall muscle and can serves as the target of feeding RNAi. Thus, after
homozygous alleles corresponding to the identified genes were introduced into 11 worms,
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as confirmed by visualization of green fluorescence after heat induction, I checked RNAi
response in the resulting worms upon mCherry dsRNA ingestion (Fig 23C). I reasoned
that mCherry dsRNA ingestion would lead to the silencing of mCherry expression in
body wall muscle if the allele to be tested specifically disrupts antiviral RNAi but not
classical RNAi. In contrast, no mCherry silencing should occur if the tested allele
disrupts both classical RNAi and antiviral RNAi. I found that, as shown in Figure 24A
and B, although enhanced FR1gfp replication was detected at comparable levels,
mCherry silencing was observed in 11 worms (Fig 23C) containing alleles corresponding

Fig 23. Results of feeding RNAi. (A) injection of unc-22 dsRNA at the concentration of 100
ng/µl induced severe twitching phenotype in N2 and drh-1 but not in 11 worms carrying rde-4
null allele and asd-1, asd-5, asd-6. (B) injection of unc-22 dsRNA at the concentration of 100
ng/µl induced severe twitching in 11 worms containing alleles corresponding to asd-2, asd-3,
asd-4, asd-7, asd-8, asd-9, asd-10, asd-11 and asd-12. (C) mCherry dsRNA ingestion would
lead to the silencing of mCherry expression in body wall muscle if the allele tested
specifically disrupts antiviral RNAi but not classical RNAi.
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to asd-2, asd-3, asd-4, asd-7, asd-8, asd-9, asd-10, asd-11 and asd-12 but not for alleles
corresponding asd-1, asd-5, asd-6. As a reconfirmation, I subjected the same set of
worms to feeding RNAi test in which the target of RNAi were endogenous genes skn-1
and unc-22. Again, as shown in Table 6, penetrating RNAi phenotype, manifested as
dead eggs or twitching progenies, were observed in genetic alleles asd-2, asd-3, asd-4,
asd-7, asd-8, asd-9, asd-10, asd-11 and asd-12 but not for asd-1, asd-5, asd-6. To rule
out the possibility that the differential requirement of the identified genes in classical
RNAi is an artifact associated with dsRNA feeding I tested the same set of worm mutants
in RNAi response triggered by unc-22 dsRNA microinjection. As shown in Figure 23 A
and B, injection of unc-22 dsRNA at the concentration of 100 ng/µl induced severe
twitching phenotype in the progenies of injected N2 worms and 11 worms carrying drh-1
null allele tm1329 and rrf-1 null allele ok589 but not in 11 worms carrying rde-4 null
allele ne337. The same treatment induced strong twitching phenotype in progenies
carrying alleles corresponding to asd-2, asd-3, asd-4, asd-7, asd-8, asd-9, asd-10, asd-11
and asd-12 but not in progenies corresponding to the rest of asd genes. These
observations together suggest that some of the candidate genes specifically contribute to
antiviral silencing.
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4.4 Some of the asd genes that are dispensable in classical RNAi do not confer resistance
against Orsay virus
To find out whether the identified genes are required for antiviral RNAi against Orsay
virus, I checked Orsay virus infection in original mutants isolated from the genetic
screen. To my surprise, I found that whereas enhanced Orsay virus replication was
detected for all alleles assigned to asd-1, asd-2, asd-5, asd-6 and asd-9, such an
enhancement in Orsay virus replication was not detected for alleles assigned to asd-3,
asd-4, asd-7, asd-8, asd-10, asd-11 and asd-12. To rule out the possibility that random
mutations in the original mutants may have inhibited Orsay virus replication in those
mutants I checked Orsay virus replication in 11 worms that contain alleles corresponding
to the asd genes. Again, enhanced Orsay virus replication was detected for alleles

Fig. 24 Northern analysis of FR1gfp and Orsay virus replication of 12 asd mutant. (A)
Northern analysis of FR1gfp in classical RNAi-related mutants. (B) Northern blot analysis of
FR1gfp in antiviral dedicated mutants. (C) Northern analysis of Orsay virus replication in
classical RNAi-related mutants and antiviral dedicated mutants.
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corresponding to asd-1, asd-2, asd-5, asd-6 and asd-9 but not for alleles corresponding to
asd-3, asd-4, asd-7, asd-8, asd-10, asd-11 and asd-12 (Fig 24C). Since the latter set of
asd genes do not contribute to classical RNAi, these results thus suggest that some of the
asd genes that do not play important role in classical RNAi do not confer resistance to
Orsay virus.

4.5 Characterization of the candidate genes using Sanger sequencing
To confirm the results from genetic complementation and to further characterize the
candidate genes, Sanger sequencing was performed to examine the coding sequencing for
rde-10, rde-11, rde-12, rde-2, rde-3, and drh-3 in the candidate mutants 1031A, 1031B,
D03, D02 respectively. I chose these four alleles for further analysis mainly because they
also disrupted classical RNAi pathway. rrf-1, rde-10, rde-11, rde-12, rde-2, rde-3 and
Table 7. Candidate gene characterization by sequencing the coding sequences for known
RNAi genes
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Fig 25. Sanger sequence data found (A) a G→A single nucleotide change in rrf-1 of 1025a.
(B) a C→T single nucleotide change in rrf-1 of B09 and. (C) a G→A change from rde-3 of
1031B. All the single nucleotide changes that are shown can cause early stop codon.

Fig 26. RDVI was restored in 11/1031B candidate mutant containing the extrachromosomal
array generated. Injection of Psur-5::rde-3::UTR construct and Pmyo-2::mCherry reporter
shown in Figure 26 restored antiviral RNAi in 11/1031B candidate mutant. Shown here is the
visualization of mCherry and green fluorescence in the 11/1031B mutant that contain
extrachromosomal arrays formed by the injected plasmids 24 hours post heat induction. There
are three worms in the picture. The pictures showed the visualization of green fluorescence in
1031B mutant with (red fluorescence in head) or without (no red fluorescence in head) an
extrachromosomal array that contains Psur-5::rde-3::UTR and Pmyo-2::mCherry transgene
array. The merged image was produced by merging images recorded under red and green
fluorescence using the same exposure.
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drh-3 are known genes required for both antiviral and classical RNAi pathway. To find
out whether any of my candidate alleles are derived from these genes I sequenced the
coding regions corresponding to these genes in some of my candidates listed in Table 7.
Please note that rde-12 is a novel gene which is important for antiviral RNAi and certain
endogenous siRNAs. Its function is to produce secondary siRNA during the amplification
process [136]. As expected, 1031B has a point mutation (G to A) in rde-3 ORF, causing a
premature stop codon (Fig 25C). Alleles B09 and 1025A were also confirmed to have a
single nucleotide base change at different position in rrf-1 ORF, causing a premature stop
codon and a single amino acid change respectively (Fig 25A, B). However, no genetic
mutations were identified for other known RNAi genes in the candidate mutants
sequenced. To confirm that the single point mutation in 1031B is indeed responsible for
the loss of antiviral RNAi I delivered wild type rde-3 transgene into 1031B through
gonad injection. As shown in figure 26, introduction of wild type rde-3 successfully
restored antiviral RNAi in 1031B.

4.6 Single molecule Fluorescent In-Situ Hybridization (smFISH) of C. elegans
In Fig. 24 B and C, I have shown that some of my candidate genes (eg.1028F, 1028J)
are highly required for FHV resistance but are dispensable for antiviral defense against
Orsay virus, indicating that these genes (1) may not specifically confer resistance to
Orsay virus or (2) are unlikely to be expressed in tissues where Orsay virus commonly
replicates.
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In order to test this hypothesis, I developed a construct, named HIP::Orsay
RdRP::UTR that contains Orsay virus RNA1 under the control of heat induced promoter
(Fig 27B). The construct was used to transform 11/N2 and then was introduced into
1028J, B01, 1028F and 3495 (drh-1) by genetic cross. Surprisingly, northern blot analysis

Fig. 27 (A) Northern analysis of Orsay virus replication in transgenic candidate mutants.
Transgenic array containing Orsay virus RNA1 termed as 46 was integrated into N2 and
introduced into 3495, B01 1028F and 1028J through genetic cross. RNA samples are
extracted 24 hours after Heat induction of worms. (B) schematic structure of 46 transgene,
which is composed of Heat-Induced Promoter at 5’ end, Orsay virus RdRP sequence and UTR
at 3’ end.

detected robust Orsay virus replication in 1028J, B01, 1028F (Fig 27A), implying that
1028J, B01 and 1028F are indeed involved in antiviral defense against Orsay virus.
However, the accumulation level of Orsay virus in these mutants is still much lower
compared to that in drh-1 mutants. Since transgene-mediated delivery of Orsay virus has
bypassed the requirement of cell receptors for Orsay virus infection, this result suggests
that candidate genes corresponding to B01, 1028F and 1028J may mainly function in the
non-intestine tissue.
To test the hypothesis that B01, 1028F and 1028J may have derived from genes that
have tissue-specific function, I used single molecule fluorescent in situ hybridization
(smFISH) strategy to identify the tissues where Orsay virus replicates in

78

Fig. 28 Cell localization of Orsay viral mRNA in C. elegans. (Left) 46/N2, JU1580, rde-1,
R1D1(rde-1/drh-1), 46/3495, 11/46/B01, 11/46/1028J, 11/46/1028F mutants infected with
Orsay virus were hybridized by 0.2nM probes which is conjugated with CAL Fluor Red 610
(Biosearch Technology) and visualized by microscopy. All the worms were washed off
from plates for fixation two days after Orsay virus infection. (Right) Heat-induced 46/N2,
46/3495, 11/46/B01, 11/46/1028J, 11/46/1028F were hybridized by 0.2nM probes which is
conjugated with CAL Fluor Red 610 (Biosearch Technology) and visualized by microscopy.
All the worms (Except for the worms with intestine reporter) were washed off from plates
for fixation one day after heat induction. Worms with intestine reporter are used to show the
intestinal part in the worm body. This worm strain contains promoter that can drive
expression of mCherry only in the intestinal cells.
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mutants containing B01, 1028F or 1028J. smFISH method differs from conventional
FISH by using many short oligos (20 base pairs long) to target different part of the RNA
molecules. Each oligo is coupled with one fluorophore and thus is relatively faint. I
combine multiple coupled oligos (48 oligos) together to produce a strong signal. By using
different oligonucleotides, non-specific binding and false positive signal could be
effectively reduced. The small oligos are also allowed to penetrate different tissue,
yielding robust signal.
Previous study utilizing FISH has confirmed that Orsay virus mainly replicates in the
anterior of intestine. My smFISH tests yielded similar results (Fig 28 Left) [137]. Clearly,
as shown in Fig 28 Left, very small areas, or not at all, showed red fluorescence in 1028J,
1028F and B01 mutants infected with Orsay virus in my smFISH tests. In B01 mutants,
no red fluorophore was detected. However, in the transgenic 1028J, 1028F and B01
mutants that contain the Orsay virus transgene, much larger fluorescent regions were
observed. Interestingly, I found that Orsay virus can replicate in more intestinal regions
(anterior or middle or posterior region) in the transgenic mutants (Fig 28 Right)
compared to non-transgenic mutants infected by the virus naturally (Fig 28 Left).
Considering the observation that Orsay virus can only replicate in intestinal cells in both
transgene-derived and infection-derived condition (Fig 28), I believe that the elevated
viral replication in broader areas is because the transgene approach delivered more
viruses into the intestine cells. Collectively, the results indicate that the 1028J, 1028F and
B01 candidate genes are expressed at high level in some of the non-intestine tissues and
as a result their antiviral function has a weaker readout in the intestine cells.
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Discussion
In total, I have screened over 30 million of C. elegans mutants using an artificial virus
as reporter for loss of antiviral RNAi. I expected to identify some genes dedicated to
antiviral defense. The transgene array in the reporter strain has significantly reduced the
time and workload for characterization of candidate alleles. In total I isolated 25 alleles
which are assigned into 12 genes by genetic complementation tests (Table 5). I have also
crossed candidate mutants with other known antiviral RNAi deficient mutants. Two of
the candidate genes were identified as rrf-1 and rde-3, which were further reconfirmed
through coding sequence examination (Fig 25).
rrf-1 encodes an RNA-dependent RNA Polymerase which contributes to the generation
of 22G RNAs. rrf-1 modulates somatic cell gene expression through endogenous RNAi
pathway. In addition, antiviral RNAi pathway has an amplification process which also
requires rrf-1 for secondary 22G viRNAs biogenesis [7]. In the genetic complementation
tests, I crossed 1025A and B09 with rrf-1 mutants and found that antiviral defense was
not recovered in F1 progenies. In the Sanger sequence results, I found a G→A and a
C→T single nucleotide change in 1025A and B09 respectively (Fig 25A, B) giving rise
to a TGA and a TAG stop codon respectively.
mut-2/rde-3 encodes a nucleotidyltransferase which is a member of the polymerase
beta nucleotidyltransferase superfamily. A G to A nucleotide change was discovered at
position 335 in rde-3 coding sequence in 1031B (Fig 25C), which caused an early stop
codon. rde-3 is required for feeding RNAi but not for transgene-derived RNAi. Loss of
RDE-3 function produces rde phonotype, indicating the importance of MUT-2/RDE-3
polymerase function in RNAi [138]. The fact that loss of mut-2/rde-3 results in depletion
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of 22G RNAs implies that rde-3 is important for secondary siRNA amplification but less
essential for primary siRNA production [111, 139, 140]. The function of rde-3 is not well
understood. One tentative conclusion is that rde-3 may be implicated in the adenylation
of mRNA, so aberrant transcripts without being processed by rde-3 could be degraded
and compete for limited RNAi components, thus reducing the ability of cell to initiate
RNAi. It is also possible that rde-3 may be involved in recruitment of RdRP in the 22G
RNAi amplification process.
Previously it has been shown that EMS mutagenesis mainly causes G to A or C to T
single nucleotide change [17]. This is further confirmed in my genetic screen, in which G
to A or C to T changes caused function loss for both rde-3 and rrf-1. These findings
suggest that in future work on mapping and identification of unknown candidate genes, I
should mainly focus on single nucleotide changes, such as G to A or C to T, especially
those changes that give rise to stop codon and key amino acid change. This kind of
changes in intron sequences should be ignored. Last but not the least, the multiple hits on
a single gene such as rrf-1 and asd-1 suggest that my biased genetic screen had a good
coverage on RDVI genes whose antiviral function can be compromised without affecting
worm viability.
Surprisingly, I found that 7 of the candidate genes that specifically contribute to
antiviral RNAi do not confer detectable resistance to intestine-infecting Orsay virus
(Figure 24C). Previous study found that the tissue-specific infection pattern of Orsay
virus remains unchanged, even when the virus replication is launched from a transgene
transcriptionally active in non-intestine tissues. This observation suggests that it is a viral
receptor-independent mechanism that controls the tissue-specific infection pattern for
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Orsay virus [113]. Orsay virus was originally identified in a wild C. elegans isolate
defective in antiviral RNAi [3, 110, 141]. In laboratory setups, Orsay virus infects wild
type N2 worms but only accumulates to low levels (Fig 24B, C), suggesting that Orsay
virus has a weak, if at all, activity on RNAi suppression. This finding is in agreement
with the hypothesis the replication of Orsay virus is significantly enhanced in RNAidefective mutants or in the presence of a viral RNAi suppressor [3, 7, 141, 142]. Since an
activity on RNAi suppression is required for many viruses to establish successful
infection [72], these observations support a hypothesis that some of those 7 candidate
genes isolated from this work may function in a tissue specific manner thereby to prevent
viruses other than Orsay virus from spreading out of the intestine tissue.
The intestine is a primary organ in C. elegans that is composed of 20 cells in larvae
and adults. It is important for nutrient absorption and macromolecule production [143]. I
found that in Orsay virus-infected Ju1580 and rde-1 mutants, the red fluorescence was
detected mainly in the anterior half of worm intestine (Fig 28 Left), indicating that the
intestinal cells are differentially susceptible to virus infection and cells in the anterior half
have relatively weaker antiviral activity. Interestingly there was no, or very weak,
fluorescence observed in virus-infected asd mutants corresponding to B01, 1028F and
1028J (Fig 28 Left), which support high level replication of FHV (Fig 24B). The smFISH
data together with the northern blot data suggests that some of my candidate genes are
weakly expressed in intestinal tissue but highly expressed in non-intestine cells.
Non-allelic Non-complementation happens when two alleles from different gene loci
fail to complement with each other for certain biological function. In this situation, the
proteins produced from these two gene can physically interact with each other and
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usually form a complex for functioning in the same pathway. This mechanism relates to a
dosage-based scenario. Reduced dosage at both gene loci results in great reduction of
dosage of the formed complex, leading to failure of complementation in certain pathway.
For example, in C. elegans, mut-7 encodes an exoribonuclease, which forms a complex
with RDE-2 required for efficient RNAi in vivo. In the genetic complementation test,
only 50% of the MUT-7 is available for RDE-2, which is also reduced to 50% in
heterozygous rde-2. As a result, only 25% MUT-7/RDE-2 is functional and it is not
enough for efficient RNAi. Thus, genetic complementation may not be the final answer
for the allele characterization. Therefore, some of the genetic alleles that were assigned to
the same genes may actually be from distinct genes. Or in other words I might have more
than 12 candidate genes.
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CHAPTER 5: MAPPING AND IDENTIFICATION OF
CANDIDATE ALLELES THROUGH WHOLE GENOME
SEQUENCING
5.1 Introduction
Following forward genetic screen genetic mapping is done to locate chromosomal
region harboring the mutation and search for the candidate mutations within the region.
Typically, a genetic cross is performed between mutant of interest and a strain of the
same species that carries genetic markers. 25% the second generation (F2) progenies from
an F1 cross or self-cross inherit the mutation of interest in homozygous status. If the
mutation is not dominant, or the wild type proteins from F1 parent can rescue the function
of the mutated proteins, these F2 progenies with the mutations can be selected based on
the phenotype. As a result, the markers for the mapping are randomly distributed in the F2
progenies, except for the genetic markers that are genetically linked to the mutation.
These linked markers which is physically close to the mutation are statistically less likely
to be involved in recombinant events than the genetic markers that are distant from the
target mutation. Therefore, the location of mutation will be revealed by the high
frequency of genetic markers surround it.
In the past, the identification of genetic alleles is usually based on restriction fragment
length polymorphism (RFLP) analysis, Amplified fragment length polymorphism
(AFLP) or Short Tandem Repeat (STR) [144-146]. These techniques are widely used
since they are inexpensive to use and easy to handle. However, owing to rapid
development of the high-throughput sequencing technologies, these old techniques
became obsoleted since they required a heavy workload and plenty of time. The use of
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Whole Genome Sequencing (WGS) based on next-generation sequencing largely reduced
the time and workload in mapping and identification genetic alleles.
WGS is the process that allows for acquiring the complete DNA sequence of the whole
genome at one time. It is a fast and effective method to pinpoint the casual mutation
caused by mutagenesis [147]. Compared to the reference genome, the mutagenized
strains always contain some mutations that significantly influence the gene function.
Therefore, it is very straightforward to map mutations to different loci in the genome and
then determine which one is the phenotype-causing one [148].
In this study, when the candidate mutant with phenotype of interest is isolated, I
crossed them with wild-type worm strain instead of strains with genetic markers. I did not
use the only worm strain with genetic marker, the Hawaii strain, because it is naturally
not resistant to virus. Therefore, if the candidate mutants were crossed with Hawaii strain,
it would be impossible to isolate homozygous candidate mutant based on the phenotype.
After crossing candidate strains with wild-type worms, the F2 progenies that carry
homozygous mutations are selected. The F2 worms without the target mutation are used
as control. Before the libraries are submitted for WGS, the genomic DNA is sheared into
small fragments, approximately 350bp in length. The DNA fragments are then ligated
with adaptor which contains index sequence.
After library construction, the worm genomic DNA will be sequenced on flow cell
lane. The templates are immobilized on the flow cell surface that is coated with lawn,
composed of oligos containing the sequence of adaptor. After the templates are
hybridized to the oligos, the bridge amplification process is carried out. In this step, the
strand fold over and adaptor region hybridized to the other oligos on the flow cell. The
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polymerase generates the complementary strand and form double strand bridge. The
bridge is then denatured, resulting in two single stand copies of template that are tethered
to the flow cell. This process is repeated over and over to generate millions of clusters,
leading to the clonal amplification of all the fragments. The reverse strands are then
cleaved and washed away, leaving forward strands on the flow cell. The sequence begins
with the extension of primer to produce reads. In each cycle, fluorescently labeled
nucleotides compete for the addition to the nucleotide chain based on the sequence of the
template. The clusters are excited by a light source after addition of each nucleotide and
the characteristic fluorescent signal is emitted. This process is termed as Sequence-BySynthesis (SBS) [149]. Millions of clusters are sequenced simultaneously, and signals are
collected. The entire deep sequencing process generates millions of reads for each
fragment. These reads are separated based on their unique indexed adaptor.
The following data analysis is carried out in Linux environment hosted by HPC (High
Performance Computing) at LSU. There has been much software developed for deep
sequencing data analysis. The initial step of mapping the deep sequencing reads to a
reference genome is alignment. In my project, I use Bowtie and BWA for short read
alignment. The Sequence Aligned Map (SAM) text-based file is then generated. Next, the
SAM file is processed using Samtools for sorting and indexing to generate Variant Call
Format (VCF) file which contains the information of single-nucleotide polymorphism
(SNP). At last I use GATK and SnpEff for SNP annotation and filtration to narrow down
the mutation pool. In total we have successfully analyzed 3 libraries though HPC data
analysis and for the first time identified mut-16 and rsd-6 as key components of worm
antiviral RNAi. rsd-6 is an orthologue of human TDRD (Tudor Domain containing)
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family. Study on this gene may shed light on antiviral defense mechanisms in mammals,
including humans.

5.2 Results
5.2.1 The principle of mapping-by-sequencing strategy
Three candidate alleles, 1031A, D02, and D03, which are involved in classical RNAi
and two candidates, B05 and 1029E which only contribute to antiviral immunity, were
selected for libraries construction. Candidate mutants were crossed with 11/N2. One
hundred F2s from the backcross were transferred to individual plates. At least 20 F2

Fig 29. Schematic of Mapping-by-sequencing strategy. Hermaphroditic EMS mutants were
crossed with male 11/N2. More than twenty F2 lines homozygous for the candidate alleles
were selected for genomic DNA extraction. 11/N2 are allowed for self-fertilization and the F1
progenies are collected for DNA extraction library construction.

strains homozygous for mutant alleles were identified by scoring the segregation of the
loss of antiviral RNAi phenotype in the F3 generation (Fig 29). The F3 populations from
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candidate group were pooled for DNA extraction and library construction. 11/N2 worms
were allowed to self-fertilize for the collection of reference genome sequence. The
mutant phenotype was further confirmed at least two times to make sure the strains all
contain homozygous mutant alleles. Random mutations originated from mutagenesis will
be unbiased distributed in the F2 progenies except for those that are physically linked to
the target mutation. Thus, I expect to see that random mutations are enriched in certain
region in worm genomes that contain the target mutation during data analysis.

5.2.2 Preparation of DNA library for whole genome sequencing
After the genomic DNA for each library was extracted following standard protocols
(chapter 2.2.7), Bioruptor, at the setting of 15 secs on and, 90 secs off, was used to obtain
small DNA fragments with sizes around 350bp. Then 10 µg from each pool was used for
library construction. To construct libraries for sequencing, I choose PCR-free Truseq
DNA kit (Illumina) to add adaptor and to perform size selection of DNA fragments.
Index sequences for each candidate mutant are listed below (Table 8). Agarose gel

Table 8. Index sequences for each library
Candidate mutants

Indexed adapter sequence

11/B05

CGATGT

11/N2

TGACCA

11/1031A

ACAGTG

11/1027E

GCCAAT

11/1029E

CAGATC

11/D03

CTTGTA
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Fig 30. Schematic of strategy to prepare library for deep sequencing

Fig 31. Size distribution for each genomic DNA library. Fig A-F are the bioanalyzer data
from 11/B05, 11/N2, 11/1031A, 11/1027E, 11/1029E and 11/D03, respectively. The peaks in
the chart represent the size (bp) and low signal intensity (F U) of the six sample libraries.

analysis and Bioanalyzer were utilized to check the quality of libraries. All the libraries
were then combined in approximately the same amount and submitted to Biotechnology
Center of University of Illinois for deep sequence (Fig 30).
Considering the high sensitivity of bioanalyzer, all of the DNA libraries were diluted
1:5 with water. Only 1μl diluted DNA of each library was run on high sensitivity DNA
chip. The charts (Fig 31 A-F) show size distribution of the six DNA libraries generated
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Fig 32. (A) Gel pattern after DNA shearing of genome DNA for 15 min 45 secs (total time:
15 secs” ON”, 90 secs “OFF”) using Bioruptor sonicator. (B) Gel pattern of DNA library
before adapter ligation (lane 1,2) and after adapter ligation (lane 3,4).

by bioanalyzer. The major peaks are in range of 500-650, suggesting that the fragments in
libraries are highly enriched at 550-600bp. The distribution of DNA fragment sizes is
within the size range we expected after adapter ligation.
I also observed DNA smear in gel electrophoresis during library construction. Figure
32A showed a distribution of DNA fragments after performing DNA shearing using
Bioruptor sonicator. The fragment sizes are around 200-400bp. Figure 32B showed a size
comparison between free DNA fragments and those from pair-end repair (lane 1, 2) and
adapter ligation (lane 3-4). There was a clear increase in fragment size after adapter
ligation.
Upon completing pair-end repair and DNA fragment size selection, the major size of
DNA smear shifts from 350 to 450bp. After adapter ligation, The DNA fragments are
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highly enriched in region corresponding to 550-600bp, indicating that adaptors are
successfully ligated to the DNA fragments (Fig 31, Fig 32).

5.2.3 Whole genome sequencing through deep sequencing
The samples were multiplexed to have six libraries in one lane on flow cell for singleread sequencing. The reads were generated at the size of 160nt on an Illumina 2500. The
pool has been sequenced to produce over 181 million reads (Table 9) with near perfect
quality scores.
Table 9. Number of reads generated for each library sequenced on an Illumina 2500
1027E

1027E_GCCAAT_L001_R1_001.fastq

34,103,615

1029E

1029E_CAGATC_L001_R1_001.fastq

40,675,540

1031A

1031A_ACAGTG_L001_R1_001.fastq

26,295,574

B05

B05_CGATGT_L001_R1_001.fastq

17,390,232

D03

D03_CTTGTA_L001_R1_001.fastq

23,080,756

N2

N2_TGACCA_L001_R1_001.fastq

39,730,386

Total Reads:

181,276,103

The libraries were first quantitated by qPCR and then sequenced on one lane for 161
cycles from one end of the fragments on a HiSeq 2500 using a HiSeq SBS sequencing kit
version 4.
Fasta files were generated and demultiplexed with the bcl2fastq v2.17.1.14 conversion
software (Illumina).
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Fig 33. Per base sequence quality of each library. This graph shows the quality of each base at
each position in the reads. The Y-axis on the graph shows the quality score, the higher the
score the better. The X-axis on the graph represents the base position. The red line in the
yellow box represents the median value of score. The Yellow box represents the inter-quartile
range. The blue line represents the mean quality.

FastQC was used to determine the quality of raw Fasta data. As shown in Figure 33,
the reads generated from all 6 libraries produced very high-quality scores, which are
around 36 points from the beginning of the sequence through to the end. Therefore,
further trimming is not necessary for these Fasta files.

5.2.4 Deep Sequencing Data Analysis
5.2.4.1 The pipeline for sequencing reads analysis

Genome resequencing is applied to achieve at least 30x coverage of the reads. The
causal mutation was identified by interrogating the whole-genome resequencing data
from each base-pair of wild type and mutant pools used. As shown in Fig 35, at the first
step, I used bowtie and BWA to align 160bp DNA reads to the reference sequence to
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create a SAM file, which is utilized to store biological sequences aligned to reference
sequence. The major differences between BWA and Bowtie are the speed of alignment
and sensitivity. BWA counts occurrences and provides mapping quality, making it more
than four times slower than Bowtie. However, BWA yields more valid matches than
bowtie though the differences are not significant. In other words, BWA has relatively
higher sensitivity. Therefore, I used both of them for comparison and reconfirmation.

Fig 34. Schematic representation of Strategy to analyze deep sequence data. All the Fasta data
were aligned to WS235 reference by Bowtie/BWA to generate SAM file. The Aligned
sequences are then sorted, merged, and indexed by Samtools to produce VCF. Two software
SnpEff and GATK are used to mediate annotation and filter of VCF.

Next, I used Samtools to sort and index the aligned sequences and generate VCF files
that can be used to store the information of the SNPs or indels or Frameshift mutations
compared to reference genome. To deal with alignment sequences, the first step is to
convert SAM file to its binary format, the BAM file, since the binary format is easier for
computer programs to work on. However, the BAM file generated from Fasta files are in
random order with regard to their position in the reference genome. In order to make it
easier to manipulate, the file must be sorted so that the alignment sequences can display
in “genome order”. That means the sequences are ordered based on the position of each
genome. Another important procedure before generating VCF file is indexing. Indexing
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the sorted BAM file allows for quick extraction of alignment sequences in particular
genome region. Then Samtools “mpileup” command was used to generate variant data by
comparing between the reference sequences and sorted alignment file. For example, to
obtain e the VCF file of D03 library, we use the following command line:

The command line means the sorted D03 bam file (D03.sort.bam) was compared with
reference genome (C. elegans genomeWS235.fa) to generate BCF file for D03. BCF is
the binary version of VCF file. Other options such as -uf or -bvcg are used to determine
the input or output format of the files.
In the end, after converting BCF to VCF file, the VCF file was annotated and filtered
to extract the information of interest. The modified VCF file can show how much impact
each SNP or INDEL could bring to the mutated genes (Fig 34). In my study, I mainly
focus on SNP since it is the major mutation type that EMS causes. In addition, I narrowed
down the candidate SNPs unique to the mutant pool by identifying those mutations
featuring a G to A or C to T change. The SNPs that can cause early stop codon or
important amino acid change are of top priority for further analysis. Subsequently, I
created VCF file for each mutant and wild type library. SNPs from each candidate library
except the mutation of interest were subtracted using SNPs from wild type as reference,
which further reduced the number of variants that need to be characterized.

5.2.4.2 Identification of mut-16 and rsd-6 as key antiviral RNAi genes

Several candidate genes were picked up for further analysis based on the impact of
corresponding SNPs on their function. I also used feeding RNAi as complementary
strategy to test their function in antiviral RNAi. After some candidates being tested, I
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found that missense mutations usually are much less likely to be the mutations I was
looking for compared to the mutations that totally caused premature stop codon in the
coding sequence. Hence, I started to work on mutations with high impact on the gene
function, such as the mutations that cause stop codon or frameshifting event.

Fig 35. Sanger Results of sanger sequence for mut-16 on 1027E, D03, D02 and 1103A. (A) A
G→ A SNP is found in mut-16 of 1027E at position 1635. (B) A C→ T SNP is found in mut16 of D02 at position 2215. (C) A C→ T SNP is found in mut-16 of D03 at position 2284. (D)
A C→ T SNP is found in mut-16 of 1103A at 2459.

Eventually, I mapped D02 and D03 to B0379.3 on chromosome I, which encodes mut16. 1031A was mapped to F16D3.2 on the same chromosome I, which encodes rsd-6.
The mutations for each allele was confirmed by Sanger sequencing (Fig 35, 37). Thus,
these efforts identified mut-16 and rsd-6 as the key genes required for antiviral RNAi
respectively.
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MUT-16 was not known to be required for antiviral RNAi defense. In previous study,
MUT-16 was found to be a worm-specific protein that plays important function in
WAGO 22G RNA pathway [140]. It is required for both somatic and germline RNAi.
Loss of MUT-16 results in depletion of ERGO-1 class 26G RNAs and 22G RNAs, but
not ALG-3/4 class 26G RNAs [97], suggesting an important role in endogenous RNAi
[150]. Some other studies also showed that MUT-16 recruits MUT-2, MUT-7, and MUT15 to form Mutator foci in germline for WAGO 22G RNA amplification and target
silencing [151]. In my study, two null alleles of mut-16 (D02, D03) containing early stop

Fig 36. FR1gfp can replicate in 11/N2 after feeding with dsRNA of a sequence from mut-16.
Visualization of green fluorescence in 11/N2 worms subjected to feeding RNAi targeting mut16. There are four worms in the picture, left two worms are subjected to feeding with mut-16
dsRNA and right two worms are fed with regular OP50 bacteria. Photographs were taken 24
hours after induction of the replicon replication. See content in 2.1.2 for experimental details.

codon at position 10081968 and 10083376 were identified on chromosome I, respectively
(Fig 35B, C). Another two mut-16 alleles, 1027E and 1103A which were assigned to the
same candidate gene asd-1 through genetic complementation tests, were also confirmed
by Sanger sequence (Fig 35A, D). As shown in Fig 35A, a G→ A transition, which
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results in an important amino acid change from Asp→Asn, was found in 1027E at
position 532. A C→A base change was found in mut-16 of 1103A at position 723 (Fig
35D), causing an early stop codon. As reconfirmation, I introduced a wild-type mut-16
transgene driven by a sur-5 promoter into D02 mutant. As a result, the antiviral function
in the transformed D02 worms is rescued. In addition, I selected a unique DNA sequence,
which is 452bp in length, in mut-16 for the construction of a plasmid to be used in
feeding RNAi. Then 11/N2 wild type worms were fed with bacteria engineered to
produce mut-16 dsRNA. As shown in Fig 36, the replication of FR1gfp is restored when
the function of mut-16 is specifically down-regulated. All these results thus confirmed
that asd-1 is mut-16.

Fig 37. Sanger Results of Sanger sequence for rsd-6 on 1031A, 1026A and 1031F. (A) A
C→T SNP is found in rsd-6 of 1031A at position of 290nt. (B) A C→T SNP is found in rsd-6
of 1026A at position of 430nt. (C) A G→A SNP is found in rsd-6 of 1031F at position of
157nt.

A C to T transition at position 8359112 on chromosome I caused a premature stop
codon in 1031A (Fig 37A), an rsd-6 allele which was assigned to asd-5 in our genetic
complementation test. The other two alleles of asd-5 were also analyzed by Sanger
sequencing. Similarly, a C to T change was identified in rsd-6 coding sequence in 1026A
(Fig 37B). A G to A change was identified in 1031F (Fig 37C). The fact that all three
98

mutation changes caused premature stop codon in rsd-6 open reading frame strongly
suggests that my candidate gene asd-5 is rsd-6.
Previously, rsd-6 was found to be required for RNAi activity in the germline [96]. The
protein that is most frequently found to interact with RSD-6 is RSD-2 [96]. BLAST
analysis shows that RSD-6 contains a Tudor domain, a structure frequently found in RNA
binding proteins although itself is not believed to be an RNA binding motif. This
observation suggests that RSD-6 may be able to bind RNA [152]. Since rsd-6 mutants
are resistant to skn-1 and unc-22 dsRNA feeding, I believe RSD-6 plays an essential role

Fig 38. RDVI was restored in 11/1026A mutant containing the extrachromosomal array
generated through gonad injection. Injection of Psur-5::rsd-6::UTR construct and Pmyo2::mCherry reporter shown in Figure 38 restored antiviral RNAi in 11/1206A candidate
mutant that contain FR1gfp transgene and Pmyo-3::mCherry reporter. Shown here is the
visualization of mCherry and green fluorescence in the 11/ 1026A mutants that contain
extrachromosomal arrays formed by the injected plasmids 24 hours post heat induction. There
four worms in the picture, which showed the visualization of green fluorescence in 1026A
mutant with (red fluorescence in head) or without (no red fluorescence in head) an
extrachromosomal array that contains Psur-5::rsd-6::UTR and Pmyo-2::mCherry transgene
array. The merged image was produced by merging images recorded under red and green
fluorescence using the same exposure.
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in classical RNAi. To reconfirm that the loss of antiviral RNAi in worm mutants
containing rsd-6 alleles are indeed a result of RSD-6 function disruption, I delivered wild
type rsd-6 transgene driven by the sur-5 promoter (Psur-5::rsd-6::UTR) into 1026A
mutants containing the FR1gfp viral replicon. As shown in Fig 38, GFP expression was
abolished in the transformed worms that contain the Psur-5::rsd-6::UTR transgene,
indicating that the rsd-6 alleles is indeed responsible for the loss of antiviral response in
asd-5 worms .
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5.3 Discussion
In principle, random mutations generated during mutagenesis should be randomly
distributed in the F2 progenies except for those that are closely to the target mutation.
Therefore, the target mutation can be easily identified by searching the genomic regions
in which the random mutations are enriched. However, when I used this strategy for
target mutation identification such regions that contain enriched random mutations were

Fig 39. Schematic presentation of new strategy for Mapping-by-sequencing. Hermaphroditic
EMS mutants cross with male 11/N2. F2 progenies are transferred into individual petri dish
for growth. We select at least fifty F2 candidate mutants as target mutant library and at least
fifty F2 wild type worms as control library by scoring the segregation of GFP in the F3
progenies after heat induction. All the F3 from selected F2 mutants are collected as the pool of
candidate library for subsequent DNA extraction. All the F3 from selected F2 wild type are
collected as the pool of control for subsequent DNA extraction library.
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not spotted during our initial analysis. I believe that this is partly due to the fact that EMS
mutagenesis under my experimental condition did not yield a large number of random
mutations around our target mutations. And this is the major reason that I cannot pick up
mutations of interest from B05 and 1029E candidate libraries. Therefore, alternative
strategy will be needed for our target mutation identification.
Figure 39 illustrates an alternative strategy for mapping-by-sequencing, which can be
used in our future work. In this strategy, two genomic DNA libraries, a candidate library
and a control library, will be constructed for deep sequencing. The candidate library will
be constructed for the F2 populations that contain the target mutation and random
mutations and the control library will be constructed for the F2 populations that may
contain the same set of random mutations but not the target mutations. After deep
sequencing and VCF file generation the target mutation together with closely linked
random mutations can be easily identified by removing other random mutations that are
shared between these two libraries. This is a free software package that can be used to
remove the shared random mutations through a subtraction operation. The new mappingby-sequencing strategy is expected to significantly reduce the time and workload for
target mutation identification
Success in sequencing the whole genome of an organism depends relies on the quality
of the genomic DNA library to be used for deep sequencing. Currently there are two
major strategies used for genomic DNA library construction: one is PCR amplificationdependent and the other is not. Before the success in sequencing some of my candidate
genomes, I also tried PCR-dependent protocol. This PCR-dependent method consists of 2
steps. The first step involves the ligation of universal y-yoke stubs to sheared genomic
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Fig 40. Schematic of double index 2-step library method. Input DNA fragments are attached
with Y-yoke stubs. Limited cycle PCR is used to add indexes and extend adapters to DNA
sample. As a result, full length and double indexed DNA library can be achieved.

DNA. Then limited-cycle PCR cycles were carried out to extend the fragments to fulllength dual-indexed libraries (Fig 40). In my experience this method tends to produce
broader size range of the DNA fragments, which may be generated in the PCR
amplification step.
Using an in-house developed pipeline, I have successfully analyzed 3 sets of deep
sequencing reads generated for my candidate genomes. This effort has led to the
identification of 4 mut-16 alleles (D02, 1026g/D03, 1103a and 1027e) and 3 rsd-6 alleles
(1026A, 1031A and 1031F) (Fig 35, 37). The D03 allele was not assigned to asd-1 during
the genetic complementation analyses. The D03 worms have severe developmental
defects, namely slow growth and small brood size, and as such very few F1 worms were
produced after cross, making it hard to perform statistical analysis.
mut-16 is an important gene involved in biogenesis of 22G RNAs in the ERGO-1
pathway [139]. This observation suggests that mut-16 may have a role in maintaining the
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function of secondary 22G viRNA in antiviral RNAi pathway [140]. In my study, I also
noticed that loss of mut-16 function results in abnormal physiological characteristics such
as reduced brood size, temperature sensitivity and abnormal morphology (Table 5),
indicating its role in endogenous RNAi. Currently exactly how mut-16 contributes to
antiviral RNAi requires further studies.
rsd-6 is predicted to contain a Tudor domain orthologous to TDRD5 in mammals. It is
known that Human TDRD5 is involved in repression of transposable elements and is
essential for germline integrity. Currently how rsd-6 function contributes to antiviral
activity remains largely unknown. The following 3 observations suggest that rsd-6 may
maintain germline integrity by promoting the synthesis of secondary siRNAs under some
unfavorable environments: First, the expression of rsd-6 is environmentally regulated.
Second, rsd-6 contributes to germline cell, but not somatic cell, development by
promoting secondary siRNA biogenesis. And third, RSD-6 and RSD-2 proteins form a
complex to promote RNAi spreading from somatic cells to germline cells [153-155]. In
my study, I found that all rsd-6 alleles confer resistance to RNAi triggered by feeding or
injection of dsRNA in both body wall muscle cells and intestinal cells (Table 6, Fig 23).
This finding suggests that rsd-6 is required for RNAi response in somatic cells.
Considering the function of Tudor domain, I propose that RSD-6 may promote the
biogenesis of secondary viRNAs by binding to primary viRNAs or it may facilitate the
interactions between proteins involved in secondary viRNA amplification.
Through genetic complementation tests, cDNA sequencing and whole genome
sequencing I have confirmed that no rsd-2, drh-1, rde-1 or rde-4 alleles have been
isolated from my genetic screen. Thus, co-delivery of known antiviral RNAi genes
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together with the reporter viral replicon indeed makes it possible to automatically reject
genetic mutations associated with known antiviral RNAi genes during genetic screen.
Consequently, our gene discovery efficiency has been significantly improved.
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CHAPTER 6: GENERAL DISCUSSION
Antiviral mechanisms are essential for all cellular creatures to survive. Cellular
organisms have evolved diverse antiviral mechanisms to protect them from viral
infection. In worms, insects and plants, RNAi is known as the major innate antiviral
mechanism to defend off virus attack. However, in mammals, the interferon (IFN)
response of innate immunity is defined as the most important innate antiviral mechanism.
In mammalian cells, virus-derived dsRNA can be recognized by pattern recognition
receptors (PRRs) such as Toll-like receptors (TLRs). Once the TLR-dependent pathway
is activated, the production of type-I IFN will ensue [156]. Another group of PRRs is the
so-called RIG-I-like receptors (RLRs). RLRs are able to detect cytoplasmic dsRNA
derived from virus replication [157]. All these receptors can detect the common viral
structures termed pathogen-associated molecular patterns (PAMPs) such as dsRNA
produced by replicating virus [158]. In addition to IFN, some studies also demonstrated
that antiviral proteins induced by viral dsRNA become associated PKR [159]. These
different antiviral pathways likely work together to enable a synergistic antiviral effect.
In the recent years, several studies have argued that RNAi has direct antiviral role in
mammalian cells [9, 160]. This point of view is based on the observation of accumulation
of virus-specific siRNA in different genetic backgrounds. However, the involvement of
interferon-mediated innate antiviral responses always complicates the situation since
siRNA is also the trigger of IFN response. Since miRNAs regulate the expression of
many interferon stimulated genes it is also possible that the increase of viral replication
observed in RNAi-deficient mammalian cells could be due to the loss of cellular miRNA
instead of viral siRNA. Therefore, the argument of whether RNAi as an important
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antiviral mechanism in mammalian cells still remains to be resolved. C. elegans as a
model organism has many homologous genes to human. For instance, C. elegans drh-1 is
a homolog of human RIG-I-like helicase gene, which functions in the detection of RNA
virus [3]. My study is expected to pick up some mammalian homologs with antiviral
function in C. elegans through genetic screen. Because IFN response does not exist in the
worm system, study of the worm homologs could bring us a better understanding on how
human antiviral genes work. My study may also facilitate addressing question whether
antiviral RNAi plays a major role in mammalian antiviral defense.
RNAi is a post-transcriptional gene regulatory mechanism initiated by double-stranded
RNA, including viral dsRNA. The RNA virus, usually single-stranded, can form dsRNA
during replication process, and thus serves as trigger for RNAi response. RNA viruses are
very dangerous to all kingdoms including mammals. More importantly, some of them are
very hard to destroy by the adaptive immunity because of two major reasons. First, RNA
viruses generally have much higher mutation rate compared to DNA virus because of the
lack of proof-reading ability in their replicase. Second, RNA viruses have mechanisms of
re-assortment and recombination for their genome to evolve faster [161-164]. However,
since viRNAs are directly processed from viral dsRNAs, making it almost impossible for
virus to escape the targeting of RDVI by mutating their genome. This explains why viral
infection caused diseases are often the result of perturbation of host RDVI by a viral
RNAi suppression.
RNAi has been successfully used to inhibit the replication of several human pathogens
including human immunodeficiency virus type 1, hepatitis C virus, hepatitis B virus,
poliovirus, influenza virus A and dengue virus (DENV) [165]. Thus, mechanistic study of
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RDVI holds the promise to develop novel antiviral strategies. To date, several research
groups have demonstrated that RDVI can be initiated in undifferentiated mammalian
cells and protects developing mice from the attack of lethal viral pathogen [9, 160, 166].
This discovery suggests that findings from RDVI studies may lead to the development of
novel therapy for human diseases caused by viral infection.
Artificial dsRNAs trigger potent RNAi response in diverse organisms. It has been used
to study the core mechanism of RNAi in many labs. These studies so far have identified
several classes of genes, such as Dicer, Argonaut and RdRP as key components of RNAi
[107, 167, 168]. Mechanistic studies of these genes have significantly improved our
understanding on the core mechanism of various RNAi responses, including RDVI.
However, since none of these factors are identified in RNAi response triggered by virus,
it has remained to be a very interesting topic to ask to what extent RDVI shares key
factors with other RNAi pathways.
In this project, I have successfully developed a unique reporter strain by co-delivery of
four known antiviral RNAi genes and a viral reporter gene into wild-type N2 worms (Fig
13). After these transgenes were injected into the worm gonad (Fig 11), they were
expected to form a large extrachromosomal DNA array in which each transgene has
multiple copies. I expected that when a worm strain containing this transgene array is
used for genetic screen the chance for mutagen to completely inactivate any of these 4
antiviral RNAi genes will be extremely low. Indeed, when I used genetic
complementation analysis combined with cDNA sequencing and whole genome
sequencing to characterize my candidate alleles, none of them were found to have derived
from any of those known antiviral RNAi genes. Thus, co-delivery of known antiviral
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RNAi genes indeed significantly expedites my gene discovery process. Transforming
worms with a combination of many target constructs can be done in any labs with basic
worm transformation facilities. Thus, this strategy can be adopted to discover genes in
other biological pathways in the worm systems.
Interestingly, 7 of my candidate genes appeared to confer antiviral function
specifically against FHV but not Orsay virus (Fig 24B, C). Orsay virus is known to
specifically infect intestine cells in C. elegans. These observations together suggest that
those 7 candidate genes may mainly function in the non-intestine cells and as such their
antiviral activity cannot be detected during Orsay virus infection. To test the hypothesis, I
used smFISH technology to detect Orsay virus genomic RNAs in the infected candidate
mutants. Indeed, I could only see weak viral replication in the anterior part of the
intestine in some of the candidate mutants (Fig 28 Left). To further confirm this result, I
delivered Orsay virus into the candidate mutants using the transgene strategy, which
would have bypassed the requirement of cell receptor for Orsay virus to gain cell entry
(Fig 27B). Again, weak viral replication was detected only in some of the transgenic
mutants that carry the Orsay virus transgene (Fig 28 Right). Interestingly, the transgenederived Orsay virus seems able to infect more intestine cells, including cells in the
posterior part of the intestine (Fig 28 Right). However, since the overall viral replication
level is increased in the transgene-mediated viral inoculation I believe that the detected
enhancement of viral replication in posterior intestine cells is mainly because more
viruses are introduced into the cells when transgene strategy was used for virus delivery.
Previously it has been noticed that although the heat inducible promoter that drives the
viral transgene is equally active in almost all worms FHV always replicates to a much
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higher in the intestine cells, suggesting that the intestine cells are naturally less resistant
to viral infection. It is therefore likely that those 7 candidate genes mainly function in the
non-intestine cells to confer antiviral resistance.
Some mammalian genes also function in a tissue-specific manner. For example,
approximately 7835 human proteins exhibit a significantly increased expression level in
some tissues. With regard to antiviral genes, it was discovered that some IFN-stimulated
genes, such as ISG54 and ISG56, were also found to be expressed in a tissue-specific
manner [169]. Some studies demonstrated that the chicken homologues of interferon
regulated genes (IRGs) also have a highly tissue specific and time specific expression
pattern as their expression level are distinct between spleen and lung over time [170].
These observations together suggest that tissue-specific gene plays an important role in
metazoan biology, and they are the major factor that affects the outcome of virus
infection. Apparently, the identification of tissue-specific antiviral genes in C. elegans, if
reconfirmed in our future study, makes it possible to study their function and mechanism
in a model organism. Findings from this study may have important input to study of
homologous mammalian genes in the antiviral response.
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